Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules

The collection of whole blood samples on paper, known as dried blood spot (DBS), dates back to the early 1960s in newborn screening for inherited metabolic disorders. DBS offers a number of advantages over conventional blood collection. As a less invasive sampling method, DBS offers simpler sample c...

Full description

Saved in:
Bibliographic Details
Published inBiomedical chromatography Vol. 24; no. 1; pp. 49 - 65
Main Authors Li, Wenkui, Tse, Francis L. S.
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.01.2010
Subjects
Online AccessGet full text
ISSN0269-3879
1099-0801
1099-0801
DOI10.1002/bmc.1367

Cover

Loading…
Abstract The collection of whole blood samples on paper, known as dried blood spot (DBS), dates back to the early 1960s in newborn screening for inherited metabolic disorders. DBS offers a number of advantages over conventional blood collection. As a less invasive sampling method, DBS offers simpler sample collection and storage and easier transfer, with reduced infection risk of various pathogens, and requires a smaller blood volume. To date, DBS‐LC‐MS/MS has emerged as an important method for quantitative analysis of small molecules. Despite the increasing popularity of DBS‐LC‐MS/MS, the method has its limitations in assay sensitivity due to the small sample size. Sample quality is often a concern. Systematic assessment on the potential impact of various blood sample properties on accurate quantification of analyte of interest is necessary. Whereas most analytes may be stable on DBS, unstable compounds present another challenge for DBS as enzyme inhibitors cannot be conveniently mixed during sample collection. Improvements on the chemistry of DBS card are desirable. In addition to capturing many representative DBS‐LS‐MS/MS applications, this review highlights some important aspects of developing and validating a rugged DBS‐LC‐MS/MS method for quantitative analysis of small molecules along with DBS sample collection, processing and storage. Copyright © 2009 John Wiley & Sons, Ltd.
AbstractList The collection of whole blood samples on paper, known as dried blood spot (DBS), dates back to the early 1960s in newborn screening for inherited metabolic disorders. DBS offers a number of advantages over conventional blood collection. As a less invasive sampling method, DBS offers simpler sample collection and storage and easier transfer, with reduced infection risk of various pathogens, and requires a smaller blood volume. To date, DBS-LC-MS/MS has emerged as an important method for quantitative analysis of small molecules. Despite the increasing popularity of DBS-LC-MS/MS, the method has its limitations in assay sensitivity due to the small sample size. Sample quality is often a concern. Systematic assessment on the potential impact of various blood sample properties on accurate quantification of analyte of interest is necessary. Whereas most analytes may be stable on DBS, unstable compounds present another challenge for DBS as enzyme inhibitors cannot be conveniently mixed during sample collection. Improvements on the chemistry of DBS card are desirable. In addition to capturing many representative DBS-LS-MS/MS applications, this review highlights some important aspects of developing and validating a rugged DBS-LC-MS/MS method for quantitative analysis of small molecules along with DBS sample collection, processing and storage.
The collection of whole blood samples on paper, known as dried blood spot (DBS), dates back to the early 1960s in newborn screening for inherited metabolic disorders. DBS offers a number of advantages over conventional blood collection. As a less invasive sampling method, DBS offers simpler sample collection and storage and easier transfer, with reduced infection risk of various pathogens, and requires a smaller blood volume. To date, DBS‐LC‐MS/MS has emerged as an important method for quantitative analysis of small molecules. Despite the increasing popularity of DBS‐LC‐MS/MS, the method has its limitations in assay sensitivity due to the small sample size. Sample quality is often a concern. Systematic assessment on the potential impact of various blood sample properties on accurate quantification of analyte of interest is necessary. Whereas most analytes may be stable on DBS, unstable compounds present another challenge for DBS as enzyme inhibitors cannot be conveniently mixed during sample collection. Improvements on the chemistry of DBS card are desirable. In addition to capturing many representative DBS‐LS‐MS/MS applications, this review highlights some important aspects of developing and validating a rugged DBS‐LC‐MS/MS method for quantitative analysis of small molecules along with DBS sample collection, processing and storage. Copyright © 2009 John Wiley & Sons, Ltd.
The collection of whole blood samples on paper, known as dried blood spot (DBS), dates back to the early 1960s in newborn screening for inherited metabolic disorders. DBS offers a number of advantages over conventional blood collection. As a less invasive sampling method, DBS offers simpler sample collection and storage and easier transfer, with reduced infection risk of various pathogens, and requires a smaller blood volume. To date, DBS-LC-MS/MS has emerged as an important method for quantitative analysis of small molecules. Despite the increasing popularity of DBS-LC-MS/MS, the method has its limitations in assay sensitivity due to the small sample size. Sample quality is often a concern. Systematic assessment on the potential impact of various blood sample properties on accurate quantification of analyte of interest is necessary. Whereas most analytes may be stable on DBS, unstable compounds present another challenge for DBS as enzyme inhibitors cannot be conveniently mixed during sample collection. Improvements on the chemistry of DBS card are desirable. In addition to capturing many representative DBS-LS-MS/MS applications, this review highlights some important aspects of developing and validating a rugged DBS-LC-MS/MS method for quantitative analysis of small molecules along with DBS sample collection, processing and storage.The collection of whole blood samples on paper, known as dried blood spot (DBS), dates back to the early 1960s in newborn screening for inherited metabolic disorders. DBS offers a number of advantages over conventional blood collection. As a less invasive sampling method, DBS offers simpler sample collection and storage and easier transfer, with reduced infection risk of various pathogens, and requires a smaller blood volume. To date, DBS-LC-MS/MS has emerged as an important method for quantitative analysis of small molecules. Despite the increasing popularity of DBS-LC-MS/MS, the method has its limitations in assay sensitivity due to the small sample size. Sample quality is often a concern. Systematic assessment on the potential impact of various blood sample properties on accurate quantification of analyte of interest is necessary. Whereas most analytes may be stable on DBS, unstable compounds present another challenge for DBS as enzyme inhibitors cannot be conveniently mixed during sample collection. Improvements on the chemistry of DBS card are desirable. In addition to capturing many representative DBS-LS-MS/MS applications, this review highlights some important aspects of developing and validating a rugged DBS-LC-MS/MS method for quantitative analysis of small molecules along with DBS sample collection, processing and storage.
Author Li, Wenkui
Tse, Francis L. S.
Author_xml – sequence: 1
  givenname: Wenkui
  surname: Li
  fullname: Li, Wenkui
  email: wenkui.li@novartis.com
  organization: Drug Metabolism and Pharmacokinetics, Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, NJ 07936, USA
– sequence: 2
  givenname: Francis L. S.
  surname: Tse
  fullname: Tse, Francis L. S.
  organization: Drug Metabolism and Pharmacokinetics, Novartis Institutes for Biomedical Research, One Health Plaza, East Hanover, NJ 07936, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20017122$$D View this record in MEDLINE/PubMed
BookMark eNp10EtPGzEUBWALUUF4SP0FlXftZoJfGcdLSIFSJbwRS8v2eMDFYwd7Bpp_z0AAqYiu7uJ-5yzOBlgNMVgAvmI0xAiRHd2YIaYlXwEDjIQo0BjhVTBApBQFHXOxDjZy_oMQEiXha2CdIIQ5JmQAzM_kbAW1j7GCeR5bmFUz9y7cQBegiY12QbUuBvjo2ls4nRSzi53ZBaxjgvedCq1r-_eDhSoov8guw1jD3CjvYRO9NZ23eQt8qZXPdvv1boKrg_3Lya9ienJ4NNmdFoYKwguuTWlYxdm4ZpRpojFlxJRVRSmhfFSX1DBhmS0xHVFLiTKCkEppzWojEBZ0E3xf9s5TvO9sbmXjsrHeq2BjlyXv-1CfZb389io73dhKzpNrVFrIt1168GMJTIo5J1u_E4zk8-Syn1w-T97T4QdqXjaJoU3K-c8CxTLw6Lxd_LdY7s0m_3qXW_v33at0J_svH8nr40M5Pj0_-H02vZSUPgEYlp_J
CitedBy_id crossref_primary_10_1002_bmc_4068
crossref_primary_10_1002_dta_2195
crossref_primary_10_4155_bio_14_205
crossref_primary_10_1016_j_microc_2017_03_057
crossref_primary_10_2174_1573411018666220818103236
crossref_primary_10_1080_10408363_2017_1297358
crossref_primary_10_1016_j_jchromb_2015_02_023
crossref_primary_10_1021_acs_analchem_8b04825
crossref_primary_10_1016_j_jpba_2011_11_015
crossref_primary_10_4155_bio_15_255
crossref_primary_10_1007_s00216_013_7322_2
crossref_primary_10_1038_srep22447
crossref_primary_10_1016_j_chroma_2013_07_105
crossref_primary_10_1016_j_aca_2017_11_014
crossref_primary_10_1258_la_2010_010155
crossref_primary_10_1016_j_jpba_2018_01_017
crossref_primary_10_1002_jcph_558
crossref_primary_10_4155_bio_2020_0105
crossref_primary_10_1016_j_ejps_2015_04_008
crossref_primary_10_1016_j_chroma_2012_06_031
crossref_primary_10_1016_j_jchromb_2012_04_013
crossref_primary_10_1093_chromsci_bmad062
crossref_primary_10_1021_acs_analchem_6b01145
crossref_primary_10_3390_colloids3030053
crossref_primary_10_1007_s11095_013_1286_y
crossref_primary_10_1002_dta_342
crossref_primary_10_1016_j_jpba_2011_03_025
crossref_primary_10_1002_rcm_6856
crossref_primary_10_1016_j_jchromb_2011_03_048
crossref_primary_10_1007_s11306_020_01703_0
crossref_primary_10_3390_molecules29050975
crossref_primary_10_1515_cclm_2022_0311
crossref_primary_10_1016_j_bbalip_2011_05_009
crossref_primary_10_1517_17425255_2014_885502
crossref_primary_10_1002_bmc_2905
crossref_primary_10_1159_000350392
crossref_primary_10_1002_sscp_202100008
crossref_primary_10_1021_acs_jproteome_0c00271
crossref_primary_10_1208_s12248_012_9430_x
crossref_primary_10_2139_ssrn_4098498
crossref_primary_10_1002_rcm_7808
crossref_primary_10_1089_thy_2016_0452
crossref_primary_10_1016_j_jchromb_2011_10_008
crossref_primary_10_1016_j_jchromb_2015_02_032
crossref_primary_10_1016_j_jpba_2022_114591
crossref_primary_10_4155_bio_2019_0020
crossref_primary_10_1586_14789450_2014_904204
crossref_primary_10_15406_japlr_2016_03_00070
crossref_primary_10_1016_j_jpba_2018_10_010
crossref_primary_10_1021_acs_analchem_7b00943
crossref_primary_10_1021_ac3018229
crossref_primary_10_1016_j_aca_2017_11_041
crossref_primary_10_1016_j_jpba_2013_07_025
crossref_primary_10_1039_C6AY01880G
crossref_primary_10_1016_j_jpba_2013_08_033
crossref_primary_10_4155_bio_2020_0319
crossref_primary_10_1016_j_jpba_2010_08_032
crossref_primary_10_1039_c1ay05160a
crossref_primary_10_1111_j_1460_9592_2011_03535_x
crossref_primary_10_1177_1091581812447957
crossref_primary_10_2215_CJN_10471012
crossref_primary_10_5812_ijp_117073
crossref_primary_10_1016_j_jchromb_2011_11_035
crossref_primary_10_4155_bio_2015_0028
crossref_primary_10_4155_bio_2019_0041
crossref_primary_10_1002_rcm_4990
crossref_primary_10_1016_j_jpba_2023_115314
crossref_primary_10_1016_j_aca_2018_06_049
crossref_primary_10_1093_jalm_jfae003
crossref_primary_10_1016_j_fct_2016_11_002
crossref_primary_10_1016_j_chroma_2020_461092
crossref_primary_10_1007_s11419_017_0391_8
crossref_primary_10_1002_bmc_5130
crossref_primary_10_1111_bcp_13553
crossref_primary_10_4155_bio_2020_0211
crossref_primary_10_1016_j_clinbiochem_2016_12_008
crossref_primary_10_1021_acs_analchem_6b01280
crossref_primary_10_1021_ac400590c
crossref_primary_10_1186_s12985_023_02225_6
crossref_primary_10_1016_j_jpba_2018_07_011
crossref_primary_10_1007_s00216_011_4740_x
crossref_primary_10_3390_pr8111500
crossref_primary_10_1016_j_jpba_2010_07_015
crossref_primary_10_1007_s10549_014_2999_2
crossref_primary_10_1002_aic_17088
crossref_primary_10_1002_bmc_4270
crossref_primary_10_1007_s00216_018_0993_y
crossref_primary_10_5402_2012_828719
crossref_primary_10_1002_jcla_22220
crossref_primary_10_1016_j_forc_2022_100438
crossref_primary_10_1016_j_jchromb_2015_03_026
crossref_primary_10_1021_ac403672u
crossref_primary_10_1002_bmc_5553
crossref_primary_10_1155_2018_3235072
crossref_primary_10_1002_bmc_5555
crossref_primary_10_1186_s12986_017_0182_6
crossref_primary_10_1007_s00414_012_0815_2
crossref_primary_10_4155_bio_14_162
crossref_primary_10_1016_j_jmsacl_2021_01_003
crossref_primary_10_4155_bio_12_321
crossref_primary_10_1021_acs_analchem_8b04420
crossref_primary_10_4155_bio_13_121
crossref_primary_10_1016_j_jpba_2014_03_013
crossref_primary_10_1093_jac_dks011
crossref_primary_10_4155_bio_12_309
crossref_primary_10_1051_ata_2010019
crossref_primary_10_1038_clpt_2011_247
crossref_primary_10_4155_bio_14_156
crossref_primary_10_4155_bio_14_157
crossref_primary_10_1016_j_talanta_2013_04_027
crossref_primary_10_1097_FTD_0000000000000224
crossref_primary_10_1021_acs_analchem_6b02199
crossref_primary_10_1007_s11095_016_2040_z
crossref_primary_10_1128_AAC_00297_10
crossref_primary_10_1186_s12263_016_0527_1
crossref_primary_10_1016_j_jchromb_2023_123592
crossref_primary_10_1016_j_trac_2016_07_010
crossref_primary_10_4155_bio_11_56
crossref_primary_10_4155_bio_12_25
crossref_primary_10_1016_j_jpba_2021_114280
crossref_primary_10_1007_s00216_013_6999_6
crossref_primary_10_1016_j_pbb_2017_09_002
crossref_primary_10_1021_acs_analchem_0c00087
crossref_primary_10_1021_acs_jproteome_4c00233
crossref_primary_10_1016_j_jpba_2011_08_011
crossref_primary_10_1016_j_talanta_2016_06_025
crossref_primary_10_4155_bio_11_19
crossref_primary_10_1016_j_chroma_2016_08_057
crossref_primary_10_1016_j_jtemb_2018_09_009
crossref_primary_10_1186_s40543_021_00300_7
crossref_primary_10_4155_bio_10_51
crossref_primary_10_4155_bio_13_227
crossref_primary_10_1074_mcp_M112_022442
crossref_primary_10_1155_2016_6053295
crossref_primary_10_1016_j_talanta_2014_10_041
crossref_primary_10_1021_acs_analchem_7b03265
crossref_primary_10_1016_j_cbpa_2017_11_002
crossref_primary_10_1016_j_jchromb_2011_12_012
crossref_primary_10_1002_jms_3236
crossref_primary_10_1093_jat_bky064
crossref_primary_10_1016_j_scitotenv_2014_06_142
crossref_primary_10_1208_s12248_010_9188_y
crossref_primary_10_1097_FTD_0000000000000127
crossref_primary_10_1111_petr_12983
crossref_primary_10_1016_j_jmsacl_2022_06_002
crossref_primary_10_1016_j_jchromb_2014_11_032
crossref_primary_10_1039_C8AN01422A
crossref_primary_10_1002_elps_201800363
crossref_primary_10_1007_s00216_015_8674_6
crossref_primary_10_1128_AAC_01054_12
crossref_primary_10_4155_bio_13_214
crossref_primary_10_3390_pr9030450
crossref_primary_10_1016_j_toxac_2014_02_007
crossref_primary_10_1007_s00216_011_5655_2
crossref_primary_10_1080_10826076_2018_1492935
crossref_primary_10_1002_mas_21601
crossref_primary_10_1016_j_jpba_2011_06_022
crossref_primary_10_4155_bio_14_126
crossref_primary_10_1016_j_jpba_2017_08_030
crossref_primary_10_1016_j_jpba_2011_12_018
crossref_primary_10_1016_j_jpba_2016_06_026
crossref_primary_10_3390_molecules24203636
crossref_primary_10_4155_bio_13_21
crossref_primary_10_1002_jms_3015
crossref_primary_10_1016_j_gene_2013_11_101
crossref_primary_10_1002_ange_201812077
crossref_primary_10_3923_jbs_2020_65_72
crossref_primary_10_1002_prca_201600103
crossref_primary_10_1002_bmc_4668
crossref_primary_10_1021_acs_analchem_8b02046
crossref_primary_10_4155_bio_11_81
crossref_primary_10_1016_j_scitotenv_2022_158716
crossref_primary_10_1016_j_trac_2016_01_030
crossref_primary_10_4155_bio_2017_0269
crossref_primary_10_1097_FTD_0000000000000302
crossref_primary_10_1097_FTD_0000000000000422
crossref_primary_10_4155_bio_14_236
crossref_primary_10_4155_bio_13_27
crossref_primary_10_1111_bcp_13840
crossref_primary_10_4155_bio_11_97
crossref_primary_10_1021_ac101421b
crossref_primary_10_4155_bio_12_69
crossref_primary_10_4155_bio_13_311
crossref_primary_10_1039_C4AY02599G
crossref_primary_10_1002_bmc_4445
crossref_primary_10_1002_jssc_201000911
crossref_primary_10_1021_acs_analchem_5b04059
crossref_primary_10_1021_ac502785j
crossref_primary_10_1002_rcm_7033
crossref_primary_10_1016_j_nano_2023_102724
crossref_primary_10_4155_bio_10_94
crossref_primary_10_4155_bio_10_96
crossref_primary_10_4155_bio_10_99
crossref_primary_10_2144_btn_2019_0043
crossref_primary_10_4155_bio_10_91
crossref_primary_10_1002_bmc_5762
crossref_primary_10_1016_j_aca_2016_08_025
crossref_primary_10_1586_14789450_2014_965158
crossref_primary_10_24911_JBCGenetics_183_1563341940
crossref_primary_10_1038_s41598_022_22990_8
crossref_primary_10_1016_j_aca_2013_04_061
crossref_primary_10_1016_j_jpba_2016_06_012
crossref_primary_10_1039_D0AY02365E
crossref_primary_10_1177_1091581811429493
crossref_primary_10_1007_s00216_011_5161_6
crossref_primary_10_1021_acs_analchem_2c00017
crossref_primary_10_1097_FTD_0000000000000560
crossref_primary_10_1016_j_jchromb_2013_02_035
crossref_primary_10_1111_bcp_13939
crossref_primary_10_4155_bio_11_72
crossref_primary_10_2217_pme_10_76
crossref_primary_10_4155_bio_13_11
crossref_primary_10_4155_bio_12_42
crossref_primary_10_4155_bio_15_127
crossref_primary_10_1016_j_cca_2014_11_007
crossref_primary_10_4155_bio_11_231
crossref_primary_10_4155_bio_2017_0231
crossref_primary_10_1097_FTD_0000000000000997
crossref_primary_10_4155_bio_11_112
crossref_primary_10_1021_acs_analchem_9b03952
crossref_primary_10_1016_j_jchromb_2018_04_039
crossref_primary_10_4155_bio_11_119
crossref_primary_10_1002_dta_2518
crossref_primary_10_1002_rcm_8100
crossref_primary_10_1016_j_jchromb_2014_12_033
crossref_primary_10_1016_j_trac_2024_117657
crossref_primary_10_1016_j_jpba_2013_11_017
crossref_primary_10_4155_bio_12_167
crossref_primary_10_4155_bio_12_168
crossref_primary_10_1002_dta_1421
crossref_primary_10_1016_j_jchromb_2012_08_036
crossref_primary_10_1002_bmc_1580
crossref_primary_10_4155_bio_2017_0221
crossref_primary_10_1002_bmc_2795
crossref_primary_10_1097_FTD_0000000000000502
crossref_primary_10_1080_10937404_2019_1661588
crossref_primary_10_1063_5_0222244
crossref_primary_10_4155_bio_11_128
crossref_primary_10_1080_17425255_2016_1201066
crossref_primary_10_1016_j_jpba_2019_112870
crossref_primary_10_1039_C5AY01514F
crossref_primary_10_1016_j_jchromb_2013_10_035
crossref_primary_10_4155_bio_15_12
crossref_primary_10_1016_j_jchromb_2013_02_005
crossref_primary_10_1016_j_jpba_2021_114542
crossref_primary_10_1016_j_jchromb_2011_06_030
crossref_primary_10_1080_10826076_2023_2284737
crossref_primary_10_4155_bio_10_208
crossref_primary_10_4155_bio_13_194
crossref_primary_10_4155_bio_13_180
crossref_primary_10_3390_molecules21081067
crossref_primary_10_3390_molecules24234320
crossref_primary_10_4155_bio_11_212
crossref_primary_10_1208_s12248_015_9783_z
crossref_primary_10_1097_FTD_0000000000000411
crossref_primary_10_1097_FTD_0000000000000653
crossref_primary_10_4155_bio_11_214
crossref_primary_10_1002_jps_23395
crossref_primary_10_1016_j_aca_2018_01_024
crossref_primary_10_1016_j_jchromb_2015_06_014
crossref_primary_10_1016_j_jchromb_2019_06_025
crossref_primary_10_1016_j_talanta_2020_120747
crossref_primary_10_4155_bio_11_219
crossref_primary_10_1007_s00216_012_6043_2
crossref_primary_10_1002_dta_1646
crossref_primary_10_4155_bio_12_264
crossref_primary_10_3390_pr10071240
crossref_primary_10_1111_bcpt_13269
crossref_primary_10_4155_bio_11_220
crossref_primary_10_4155_bio_13_170
crossref_primary_10_1016_j_jpba_2024_116454
crossref_primary_10_1039_c0em00754d
crossref_primary_10_1007_s11419_023_00659_9
crossref_primary_10_1002_chem_201102935
crossref_primary_10_1097_FTD_0000000000000884
crossref_primary_10_18097_PBMC20146002201
crossref_primary_10_4155_bio_11_227
crossref_primary_10_1021_ac303205m
crossref_primary_10_3390_biomedicines12102318
crossref_primary_10_1007_s00216_022_04469_7
crossref_primary_10_4155_bio_12_85
crossref_primary_10_4155_bio_14_22
crossref_primary_10_1002_rcm_5182
crossref_primary_10_1016_j_jviromet_2012_08_016
crossref_primary_10_4155_bio_13_58
crossref_primary_10_4155_bio_14_25
crossref_primary_10_1371_journal_pgph_0003350
crossref_primary_10_4155_bio_13_175
crossref_primary_10_3390_ph17060799
crossref_primary_10_1002_adhm_202202564
crossref_primary_10_1007_s00216_016_9954_5
crossref_primary_10_4155_bio_13_171
crossref_primary_10_1016_j_forsciint_2022_111533
crossref_primary_10_3390_molecules28083466
crossref_primary_10_1016_j_trac_2017_10_002
crossref_primary_10_1021_acs_analchem_9b04845
crossref_primary_10_1016_j_taap_2014_06_013
crossref_primary_10_1002_rcm_6241
crossref_primary_10_3390_diagnostics10040248
crossref_primary_10_1016_j_jpba_2019_01_048
crossref_primary_10_1002_mas_21441
crossref_primary_10_1002_bmc_1555
crossref_primary_10_1007_s13361_013_0658_1
crossref_primary_10_1016_j_jchromb_2025_124470
crossref_primary_10_1097_FTD_0000000000000825
crossref_primary_10_1016_j_colsurfa_2015_10_056
crossref_primary_10_4155_bio_11_205
crossref_primary_10_4155_bio_11_204
crossref_primary_10_1016_j_jchromb_2021_122905
crossref_primary_10_4155_bio_11_4
crossref_primary_10_1016_j_jpha_2020_08_001
crossref_primary_10_1002_rcm_6370
crossref_primary_10_1016_j_jpba_2012_03_049
crossref_primary_10_4155_bio_12_111
crossref_primary_10_4155_bio_13_157
crossref_primary_10_1128_AAC_00845_18
crossref_primary_10_3389_fchem_2021_801043
crossref_primary_10_4155_bio_13_156
crossref_primary_10_1515_tjb_2022_0116
crossref_primary_10_3389_fphar_2021_679431
crossref_primary_10_4155_bio_12_119
crossref_primary_10_1016_j_foodres_2018_02_046
crossref_primary_10_1002_advs_202100323
crossref_primary_10_4155_bio_14_189
crossref_primary_10_1002_bmc_1572
crossref_primary_10_4155_bio_2022_0077
crossref_primary_10_4155_bio_14_185
crossref_primary_10_1002_dta_2776
crossref_primary_10_1074_mcp_O115_049957
crossref_primary_10_1039_C7AN01075C
crossref_primary_10_1016_j_eswa_2017_02_022
crossref_primary_10_3109_10408444_2011_650790
crossref_primary_10_4155_bio_2023_0156
crossref_primary_10_4155_bio_14_184
crossref_primary_10_4155_bio_2023_0044
crossref_primary_10_3389_fnut_2017_00009
crossref_primary_10_1134_S1990750814010119
crossref_primary_10_1016_j_jchromb_2012_07_011
crossref_primary_10_1093_jat_bkae081
crossref_primary_10_2174_0115734129296648240812111928
crossref_primary_10_1007_s40262_014_0150_5
crossref_primary_10_4155_bio_13_143
crossref_primary_10_1016_j_jpba_2015_07_013
crossref_primary_10_1038_jes_2013_7
crossref_primary_10_1016_j_forsciint_2015_07_004
crossref_primary_10_1128_AAC_00707_13
crossref_primary_10_1007_s00216_014_7619_9
crossref_primary_10_1093_jac_dky254
crossref_primary_10_1002_dta_3755
crossref_primary_10_1016_j_jpba_2017_02_046
crossref_primary_10_4155_bio_14_298
crossref_primary_10_1007_s00216_012_6317_8
crossref_primary_10_4155_bio_15_35
crossref_primary_10_4236_pp_2013_42022
crossref_primary_10_4155_bio_15_38
crossref_primary_10_1002_dta_1698
crossref_primary_10_1016_j_talanta_2013_09_010
crossref_primary_10_1016_j_jpba_2016_09_036
crossref_primary_10_1016_j_chemosphere_2011_12_077
crossref_primary_10_1093_jat_bkaa106
crossref_primary_10_1002_btm2_10476
crossref_primary_10_1002_ejlt_201700362
crossref_primary_10_4155_bio_10_155
crossref_primary_10_1134_S1061934822040104
crossref_primary_10_1007_s40263_013_0050_5
crossref_primary_10_4155_bio_10_159
crossref_primary_10_4155_bio_10_157
crossref_primary_10_1002_bmc_1752
crossref_primary_10_4155_bio_11_193
crossref_primary_10_4155_bio_2016_0110
crossref_primary_10_1007_s00216_012_6440_6
crossref_primary_10_1016_j_talanta_2013_12_043
crossref_primary_10_1007_s10337_024_04341_z
crossref_primary_10_1016_j_clinbiochem_2016_07_018
crossref_primary_10_1016_j_xphs_2016_01_021
crossref_primary_10_4155_bio_15_99
crossref_primary_10_1002_anie_201812077
crossref_primary_10_1002_rcm_6212
crossref_primary_10_1371_journal_pone_0108190
crossref_primary_10_5702_massspectrometry_S0060
crossref_primary_10_4155_bio_15_94
crossref_primary_10_1007_s00216_015_8887_8
crossref_primary_10_1038_srep45178
crossref_primary_10_1021_acs_analchem_5b02996
crossref_primary_10_1007_s00394_025_03629_6
crossref_primary_10_1016_j_jchromb_2017_11_005
crossref_primary_10_4155_bio_11_178
crossref_primary_10_1373_clinchem_2015_247668
crossref_primary_10_4155_bio_10_133
crossref_primary_10_1016_j_jpba_2020_113102
crossref_primary_10_4155_bio_10_137
crossref_primary_10_1016_j_ces_2020_116010
crossref_primary_10_1016_j_jiph_2018_10_007
crossref_primary_10_1002_bmc_3958
crossref_primary_10_4155_bio_15_63
crossref_primary_10_1016_j_colsurfa_2014_03_033
crossref_primary_10_4155_bio_11_293
crossref_primary_10_1002_bmc_2745
crossref_primary_10_1016_j_jpba_2013_04_007
crossref_primary_10_3390_ph14040365
crossref_primary_10_4155_bio_10_144
crossref_primary_10_1002_psp4_12881
crossref_primary_10_1016_j_jpba_2015_02_045
crossref_primary_10_1080_02770903_2017_1402341
crossref_primary_10_1002_bmc_4917
crossref_primary_10_1002_dta_1496
crossref_primary_10_4155_bio_10_149
crossref_primary_10_1016_j_jim_2013_04_006
crossref_primary_10_1016_j_jfca_2024_106340
crossref_primary_10_1016_j_chroma_2012_08_072
crossref_primary_10_1039_C0AY00714E
crossref_primary_10_1093_jac_dkv174
crossref_primary_10_1016_j_cca_2018_07_007
crossref_primary_10_4155_bio_2016_0029
crossref_primary_10_1021_acs_chemrestox_6b00334
crossref_primary_10_1016_j_clinbiochem_2013_03_027
crossref_primary_10_1016_j_jpba_2012_04_013
crossref_primary_10_4155_bio_10_111
crossref_primary_10_1039_C9AY02624J
crossref_primary_10_1097_FTD_0000000000001083
crossref_primary_10_1097_FTD_0000000000001082
crossref_primary_10_1016_j_jchromb_2011_03_017
crossref_primary_10_1016_j_jpba_2024_116518
crossref_primary_10_1016_j_pcl_2012_07_004
crossref_primary_10_1016_j_jpba_2012_04_007
crossref_primary_10_1016_j_aca_2024_343349
crossref_primary_10_3389_fchem_2019_00248
crossref_primary_10_1021_ac303014b
crossref_primary_10_1016_j_aca_2016_05_057
crossref_primary_10_1016_j_jpba_2016_02_009
crossref_primary_10_4155_bio_10_126
crossref_primary_10_3390_s22218257
crossref_primary_10_1007_s13318_023_00846_4
crossref_primary_10_1016_j_aca_2021_339231
crossref_primary_10_4155_bio_11_132
crossref_primary_10_4155_bio_2018_0144
crossref_primary_10_1016_j_forsciint_2019_03_026
crossref_primary_10_1002_jms_3952
crossref_primary_10_1002_jms_1653
crossref_primary_10_1016_j_forsciint_2011_07_024
crossref_primary_10_1016_j_jchromb_2012_05_040
crossref_primary_10_1016_j_trac_2017_12_004
crossref_primary_10_1016_j_jpba_2019_07_020
crossref_primary_10_1016_j_jchromb_2014_08_013
crossref_primary_10_1016_j_jchromb_2018_06_035
crossref_primary_10_4155_bio_10_100
crossref_primary_10_4155_bio_2016_0062
crossref_primary_10_4155_bio_10_104
crossref_primary_10_4155_bio_10_103
crossref_primary_10_52711_0974_360X_2024_00329
crossref_primary_10_3390_futurepharmacol4010011
crossref_primary_10_4155_bio_10_108
crossref_primary_10_1021_acs_analchem_7b04827
crossref_primary_10_4155_bio_10_107
crossref_primary_10_4155_bio_10_106
crossref_primary_10_1208_s12248_014_9695_3
crossref_primary_10_4155_bio_10_105
crossref_primary_10_1016_j_euroneuro_2017_01_009
Cites_doi 10.1016/j.jpba.2008.10.040
10.1016/j.jchromb.2008.05.025
10.1210/jc.2006-2890
10.1016/j.jchromb.2007.11.006
10.1002/rcm.2163
10.1016/S0378-4347(99)00111-5
10.1016/j.jchromb.2009.02.015
10.1210/jcem-45-5-1003
10.1373/clinchem.2007.098434
10.1016/j.jchromb.2005.12.010
10.1097/FTD.0b013e31819e91ce
10.1016/j.steroids.2009.02.008
10.1111/j.1365-2257.1995.tb01230.x
10.1016/j.jchromb.2004.06.018
10.1093/clinchem/38.9.1830
10.1002/jcla.2039
10.1111/j.1432-2277.2007.00584.x
10.1002/rcm.3428
10.1002/rcm.1054
10.1373/clinchem.2006.076679
10.1097/01.tp.0000188168.45003.63
10.1023/B:BOLI.0000045830.82698.90
10.1046/j.1365-2257.2003.00484.x
10.1023/A:1005424331822
10.1146/annurev.genom.3.022502.103213
10.1007/s00216-008-2505-y
10.1016/j.jpba.2008.05.010
10.1093/clinchem/46.1.122
10.1080/00313020701813743
10.1542/peds.32.3.338
10.1353/dem.2007.0038
10.1373/49.8.1375
10.1097/01.mop.0000133635.79661.84
10.1210/jc.2003-032235
10.1111/j.1528-1167.2009.02204.x
10.1016/j.jpba.2008.11.025
10.1016/j.jchromb.2005.12.015
10.1093/jat/20.3.179
10.1007/s10545-007-0691-y
10.1093/jn/131.5.1631S
10.1093/clinchem/48.2.370
10.1373/clinchem.2003.027193
10.1093/clinchem/39.6.1354
10.1016/j.jchromb.2005.01.001
10.1097/00005237-200401000-00005
10.1016/j.cca.2007.08.003
10.1093/clinchem/39.1.66
10.1097/FTD.0b013e31818d9fdb
10.1016/j.ymgme.2009.03.010
10.1002/rcm.493
10.1016/j.ymgme.2006.05.001
10.1016/j.jpba.2006.11.023
10.1016/S0009-8981(03)00292-4
10.1093/jat/32.7.511
10.1007/s00216-009-2775-z
10.1021/ac8022235
10.1016/j.jchromb.2008.01.028
10.1016/j.jpba.2008.11.021
10.1093/clinchem/41.1.62
10.1007/BF01799385
10.1177/193229680900300118
10.1016/j.jpba.2008.09.025
10.1007/s10545-008-0965-z
10.1016/j.ymgme.2005.12.005
10.1373/clinchem.2003.022178
10.1007/BF02977623
10.1093/clinchem/46.1.126
10.1016/j.jpba.2009.02.001
10.1021/ac8022839
10.1016/j.jchromb.2009.03.024
10.1016/j.cca.2006.04.013
10.1002/rcm.2158
10.1016/j.jchromb.2008.04.003
10.1006/bmme.1997.2609
10.1002/bmc.1049
10.1016/S0009-8981(02)00135-3
10.1016/j.clinbiochem.2005.12.009
10.1258/000456303763046094
10.1097/01.ftd.0000170879.18139.40
10.1136/jcp.52.9.633
10.1373/clinchem.2007.087775
10.1016/j.cca.2009.02.005
ContentType Journal Article
Copyright Copyright © 2010 John Wiley & Sons, Ltd.
Copyright_xml – notice: Copyright © 2010 John Wiley & Sons, Ltd.
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1002/bmc.1367
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Chemistry
EISSN 1099-0801
EndPage 65
ExternalDocumentID 20017122
10_1002_bmc_1367
BMC1367
ark_67375_WNG_8PRFJQLT_3
Genre reviewArticle
Journal Article
Review
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
23N
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
AQPKS
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BSCLL
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HF~
HGLYW
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LH5
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
RNS
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
UB1
V2E
W8V
W99
WBFHL
WBKPD
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRC
WRJ
WXSBR
WYISQ
XG1
XPP
XV2
ZZTAW
~IA
~WT
AAHQN
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AFWVQ
ALVPJ
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3927-7bc6c4d748f434b2b1342c6dd332375f63c49e4e61353e32ac922dabb4fc90193
IEDL.DBID DR2
ISSN 0269-3879
1099-0801
IngestDate Thu Jul 10 23:26:14 EDT 2025
Mon Jul 21 05:38:12 EDT 2025
Thu Apr 24 22:51:08 EDT 2025
Tue Jul 01 03:41:32 EDT 2025
Wed Jan 22 16:44:32 EST 2025
Wed Oct 30 09:51:52 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3927-7bc6c4d748f434b2b1342c6dd332375f63c49e4e61353e32ac922dabb4fc90193
Notes ArticleID:BMC1367
ark:/67375/WNG-8PRFJQLT-3
istex:59FBCC4F5F9BDEFCABB9BD6A2F70E13368BFB7CD
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/bmc.1367
PMID 20017122
PQID 734203534
PQPubID 23479
PageCount 17
ParticipantIDs proquest_miscellaneous_734203534
pubmed_primary_20017122
crossref_primary_10_1002_bmc_1367
crossref_citationtrail_10_1002_bmc_1367
wiley_primary_10_1002_bmc_1367_BMC1367
istex_primary_ark_67375_WNG_8PRFJQLT_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-01
January 2010
2010-01-00
2010-Jan
20100101
PublicationDateYYYYMMDD 2010-01-01
PublicationDate_xml – month: 01
  year: 2010
  text: 2010-01
PublicationDecade 2010
PublicationPlace Chichester, UK
PublicationPlace_xml – name: Chichester, UK
– name: England
PublicationTitle Biomedical chromatography
PublicationTitleAlternate Biomed. Chromatogr
PublicationYear 2010
Publisher John Wiley & Sons, Ltd
Publisher_xml – name: John Wiley & Sons, Ltd
References Johnson DW and Trinh MU. Stability of malonylcarnitine and glutarylcarnitine in stored blood spots. Journal of Inherited Metabolic Disease 2004; 27(6): 789-790.
Adam BW, Alexander JR, Smith SJ, Chace DH, Loeber JG, Elvers LH and Hannon WH. Recoveries of phenylalanine from two sets of dried-blood-spot reference materials: prediction from hematocrit, spot volume, and paper matrix. Clinical Chemistry. 2000; 46(1): 126-128.
Chen J and Hsieh Y. Stabilizing drug molecules in biological samples. Therapeutic Drug Monitoring 2005; 27(5): 617-624.
Carpenter KH and Wiley V. Application of tandem mass spectrometry to biochemical genetics and newborn screening. Clinica Chimica Acta 2002; 322(1-2): 1-10.
la Marca G, Malvagia S, Filippi L, Fiorini P, Innocenti M, Luceri F, Pieraccini G, Moneti G, Francese S, Dani FR and Guerrini R. Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method. Journal of Pharmaceutical and Biomedical Analysis 2008b; 48(5): 1392-1396.
Al-Dirbashi OY, Rashed MS, Jacob M, Al-Ahaideb LY, Al-Amoudi M, Rahbeeni Z, Al-Sayed MM, Al-Hassnan Z, Al-Owain M and Al-Zeidan H. Improved method to determine succinylacetone in dried blood spots for diagnosis of tyrosinemia type 1 using UPLC-MS/MS. Biomedical Chromatography. 2008; 22(11): 1181-1185.
Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U and Sander J. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. The Journal of Clinical Endocrinology and Metabolism 2007; 92(7): 2581-2589.
Wong T, Shackleton CH, Covey TR and Ellis G. Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays. Clinical Chemistry. 1992; 38(9): 1830-1837.
van der Heijden J, De Beer Y, HoogtanDers K, Christiaans M, De Jong GJ, Neef C and Stolk L. Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2009; 50(4): 664-670.
Magera MJ, Gunawardena ND, Hahn SH, Tortorelli S, Mitchell GA, Goodman SI, Rinaldo P and Matern D. Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I. Molecular Genetics and Metabolism 2006; 88(1): 16-21.
Guthrie R and Suzi A. A Simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963; 32: 338-343.
la Marca G, Malvagia S, Pasquini E, Innocenti M, Donati MA and Zammarchi E. Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry. Clinical Chemistry 2007; 53(7): 1364-1369.
O'Broin SD, Kelleher BP and Gunter E. Evaluation of factors influencing precision in the analysis of samples taken from blood spots on filter paper. Clinical and Laboratory Haematology 1995; 17(2): 185-188.
Sosnoff CS, Ann Q, Bernert JT Jr, Powell MK, Miller BB, Henderson LO, Hannon WH, Fernhoff P and Sampson EJ. Analysis of benzoylecgonine in dried blood spots by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry. Journal of Analytical Toxicology 1996; 20(3): 179-184.
Garg U and Dasouki M. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects. Clinical Biochemistry 2006; 39(4): 315-332.
Lai CC, Tsai CH, Tsai FJ, Wu JY, Lin WD and Lee CC. Rapid screening assay of congenital adrenal hyperplasia by measuring 17α-hydroxyprogesterone with high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots. Journal of Clinical Laboratory Analysis 2002; 16(1): 20-25.
Newman MS, Brandon TR, Groves MN, Gregory WL, Kapur S and Zava DT. A liquid chromatography/Tandem mass spectrometry method for determination of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in dried blood spots: a potential adjunct to diabetes and cardiometabolic risk screening. Journal of Diabetes Science and Technology 2009; 3(1): 156-162.
ter Heine R, Hillebrand MJ, Rosing H, van Gorp EC, Mulder JW, Beijnen JH and Huitema AD. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2009a; 49(2): 451-458.
Garcia Boy R, Henseler J, Mattern R and Skopp G. Determination of morphine and 6-acetylmorphine in blood with use of dried blood spots. Therapeutic Drug Monitoring 2008; 30(6): 733-739.
Török D, Mühl A, Votava F, Heinze G, Sólyom J, Crone J, Stöckler-Ipsiroglu S and Waldhauser F. Stability of 17alpha-hydroxyprogesterone in dried blood spots after autoclaving and prolonged storage. Clinical Chemistry 2002; 48(2): 370-372.
Banta-Wright SA and Steiner RD. Tandem mass spectrometry in newborn screening: a primer for neonatal and perinatal nurses. Journal of Perinatal and Neonatal Nursing 2004; 18(1): 41-58.
Barfield M, Spooner N, Lad R, Parry S and Fowles S. Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2008; 870(1): 32-37.
Schulze A, Schmidt C, Kohlmüller D, Hoffmann GF and Mayatepek E. Accurate measurement of free carnitine in dried blood spots by isotope-dilution electrospray tandem mass spectrometry without butylation. Clinica Chimica Acta 2003; 335(1-2): 137-145.
McDade TW, Williams S and Snodgrass JJ. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 2007; 44(4): 899-925.
Chace DH, Kalas TA and Naylor EW. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annual Review of Genomics and Human Genetics 2002; 3: 17-45.
Pang S, Hotchkiss J, Drash AL, Levine LS and New MI. Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism 1977; 45(5): 1003-1008.
Wilhelm AJ, den Burger JC, Vos RM, Chahbouni A and Sinjewel A. Analysis of cyclosporin A in dried blood spots using liquid chromatography tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2009; 877(14-15): 1595-1598.
Al-Dirbashi OY, Rashed MS, Brink HJ, Jakobs C, Filimban N, Al-Ahaidib LY, Jacob M, Al-Sayed MM, Al-Hassnan Z and Faqeih E. Determination of succinylacetone in dried blood spots and liquid urine as a dansylhydrazone by liquid chromatography tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2006; 831(1-2): 274-280.
Higashi T, Nishio T, Uchida S, Shimada K, Fukushi M and Maeda M. Simultaneous determination of 17α-hydroxypregnenolone and 17α-hydroxyprogesterone in dried blood spots from low birth weight infants using LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis 2008; 48(1): 177-182.
Rinaldo P, Tortorelli S and Matern. Recent developments and new applications of tandem mass spectrometry in newborn screening. Current Opinion in Pediatrics 2004; 16(4): 427-433.
Shigematsu Y, Hata I and Tanaka Y. Stable-isotope dilution measurement of isovalerylglycine by tandem mass spectrometry in newborn screening for isovaleric acidemia. Clinica Chimica Acta 2007; 386(1-2): 82-86.
Liang X, Li Y, Barfield M and Ji QC. Study of dried blood spots technique for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2009; 877(8-9): 799-806.
Yu HC, Tuteja S, Moon JI, Kleiner GI, Conanan L, Gaynor JJ, Kato T, Levi DM, Nishida S, Selvaggi G, Gandia C, Weppler D, Esquenazi V, Ruiz P, Miller J and Tzakis AG. Utilization of dried blood spot citrulline level as a noninvasive method for monitoring graft function following intestinal transplantation. Transplantation 2005; 80(12): 1729-1733.
Henderson LO, Powell MK, Hannon WH, Bernert JT Jr, Pass KA, Fernhoff P, Ferre CD, Martin L, Franko E, Rochat RW, Brantley MD and Sampson E. An evaluation of the use of dried blood spots from newborn screening for monitoring the prevalence of cocaine use among childbearing women. Biochemical and Molecular Medicine 1997; 61(2): 143-151.
Fingerhut R, Ensenauer R, Röschinger W, Arnecke R, Olgemöller B and Roscher AA. Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency. Analytical Chemistry 2009; 81(9): 3571-3575.
Huck JH, Struys EA, Verhoeven NM, Jakobs C and van der Knaap MS. Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass spectrometry: application to transaldolase deficiency. Clinical Chemistry 2003; 49(8): 1375-1380.
Parker SP and Cubit WD. The use of the dried blood spot samples in epidemiological studies. Journal of Clinical Pathology 1999, 52: 633-639.
Wilcken B and Wiley V. Newborn screening. Pathology, 2008; 40(2): 104-105.
Chace DH, Millington DS, Terada N, Kahler SG, Roe CR and Hofman LF. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clinical Chemistry 1993; 39(1): 66-71.
Hoogtanders K, van der Heijden J, Christiaans M, Edelbroek P, van Hooff JP and Stolk LM. Therapeutic drug monitoring of tacrolimus with the dried blood spot method.
2002; 16
2009b; 49
1990; 13
2009; 81
2004; 27
2000; 46
2008a
2006; 39
2007; 386
2008; 867
2006; 373
2008; 32
2003; 17
2008; 863
2009; 393
2004; 809
2009; 394
2008; 30
2008; 861
2007; 30
2009; 877
2005; 27
2009; 49
2002; 48
1963; 32
1993; 39
2001; 131
2009; 97
2001
2009; 50
2005; 823
2003; 49
2008; 21
2001; 15
2008; 22
2008b; 48
1999; 52
2008; 870
2003; 40
1999; 731
1996; 20
2009; 403
1997; 61
1995; 17
2004; 89
2009
2008
1997
2002; 3
2007; 92
2008; 54
2005; 80
1977; 45
1992; 38
2006; 831
2007; 53
2003; 335
1998; 21
1995; 41
2005; 19
2009; 74
2004; 50
2009; 31
2004; 18
2006; 89
2004; 16
2006; 88
2002; 322
2008; 48
2003; 25
2009a; 49
2009; 3
2008; 40
2007; 44
2008c; 22
e_1_2_1_60_1
e_1_2_1_81_1
e_1_2_1_20_1
e_1_2_1_41_1
e_1_2_1_66_1
e_1_2_1_68_1
e_1_2_1_24_1
e_1_2_1_45_1
e_1_2_1_62_1
e_1_2_1_22_1
e_1_2_1_43_1
e_1_2_1_64_1
e_1_2_1_85_1
e_1_2_1_28_1
e_1_2_1_49_1
e_1_2_1_26_1
e_1_2_1_47_1
Török D (e_1_2_1_77_1) 2002; 48
Adam BW (e_1_2_1_3_1) 2000; 46
e_1_2_1_71_1
e_1_2_1_31_1
e_1_2_1_54_1
e_1_2_1_8_1
e_1_2_1_56_1
e_1_2_1_79_1
e_1_2_1_6_1
Guthrie R (e_1_2_1_30_1) 1963; 32
e_1_2_1_35_1
e_1_2_1_50_1
e_1_2_1_73_1
e_1_2_1_4_1
e_1_2_1_10_1
e_1_2_1_33_1
e_1_2_1_52_1
e_1_2_1_75_1
e_1_2_1_2_1
e_1_2_1_16_1
e_1_2_1_39_1
e_1_2_1_14_1
e_1_2_1_37_1
Gempel K (e_1_2_1_29_1) 2000; 46
e_1_2_1_58_1
e_1_2_1_18_1
e_1_2_1_80_1
e_1_2_1_82_1
Chace DH (e_1_2_1_13_1) 1995; 41
e_1_2_1_42_1
e_1_2_1_65_1
Wong T (e_1_2_1_83_1) 1992; 38
e_1_2_1_40_1
e_1_2_1_67_1
e_1_2_1_23_1
e_1_2_1_46_1
e_1_2_1_84_1
e_1_2_1_21_1
e_1_2_1_44_1
e_1_2_1_63_1
e_1_2_1_86_1
O'Broin SD. (e_1_2_1_61_1) 1993; 39
e_1_2_1_27_1
Chace DH (e_1_2_1_12_1) 1993; 39
e_1_2_1_25_1
e_1_2_1_48_1
e_1_2_1_69_1
e_1_2_1_70_1
e_1_2_1_7_1
e_1_2_1_55_1
e_1_2_1_76_1
e_1_2_1_5_1
e_1_2_1_57_1
e_1_2_1_78_1
e_1_2_1_34_1
e_1_2_1_51_1
e_1_2_1_72_1
e_1_2_1_11_1
e_1_2_1_32_1
e_1_2_1_53_1
e_1_2_1_74_1
e_1_2_1_17_1
e_1_2_1_38_1
e_1_2_1_15_1
e_1_2_1_36_1
e_1_2_1_59_1
e_1_2_1_9_1
e_1_2_1_19_1
References_xml – reference: Fingerhut R and Olgemöller B. Newborn screening for inborn errors of metabolism and endocrinopathies: an update. Analytical and Bioanalytical Chemistry 2009; 393(5): 1481-1497.
– reference: Yoon HR. Two step derivatization for the analyses of organic, amino acids and glycines on filter paper plasma by GC-MS/SIM. Archives of Pharmaceutical Research 2007; 30(3): 387-395.
– reference: Lai CC, Tsai CH, Tsai FJ, Wu JY, Lin WD and Lee CC. Rapid screening assay of congenital adrenal hyperplasia by measuring 17α-hydroxyprogesterone with high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots. Journal of Clinical Laboratory Analysis 2002; 16(1): 20-25.
– reference: van der Heijden J, De Beer Y, HoogtanDers K, Christiaans M, De Jong GJ, Neef C and Stolk L. Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2009; 50(4): 664-670.
– reference: Gempel K, Gerbitz KD, Casetta B and Bauer MF. Rapid determination of total homocysteine in blood spots by liquid chromatography-electrospray ionization-tandem mass spectrometry. Clinical Chemistry 2000; 46(1): 122-123.
– reference: O'Broin SD. Influence of hematocrit on quantitative analysis of 'blood spots' on filter paper. Clinical Chemistry 1993; 39(6): 1354-1355.
– reference: Cheung CY, van der Heijden J, HoogtanDers K, Christiaans M, Liu YL, Chan YH, Choi KS, Van De Plas A, Shek CC, Chau KF, Li CS, Van Hooff J and Stolk L. Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation. Transplant International 2008; 21(2): 140-145.
– reference: Adam BW, Alexander JR, Smith SJ, Chace DH, Loeber JG, Elvers LH and Hannon WH. Recoveries of phenylalanine from two sets of dried-blood-spot reference materials: prediction from hematocrit, spot volume, and paper matrix. Clinical Chemistry. 2000; 46(1): 126-128.
– reference: Parker SP and Cubit WD. The use of the dried blood spot samples in epidemiological studies. Journal of Clinical Pathology 1999, 52: 633-639.
– reference: Chace DH, Millington DS, Terada N, Kahler SG, Roe CR and Hofman LF. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. Clinical Chemistry 1993; 39(1): 66-71.
– reference: Fingerhut R. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values. Steroids 2009; 74(8): 662-5
– reference: la Marca G, Malvagia S, Pasquini E, Innocenti M, Fernandez MR, Donati MA and Zammarchi E. The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs. Rapid Communications in Mass Spectrometry 2008c; 22(6): 812-818
– reference: Matern D, Tortorelli S, Oglesbee D, Gavrilov D and Rinaldo P. Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: the Mayo Clinic experience (2004-2007). Journal of Inherited Metabolic Disease 2007; 30(4): 585-592.
– reference: Magera MJ, Gunawardena ND, Hahn SH, Tortorelli S, Mitchell GA, Goodman SI, Rinaldo P and Matern D. Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I. Molecular Genetics and Metabolism 2006; 88(1): 16-21.
– reference: Abdenur JE, Chamoles NA, Guinle AE, Schenone AB and Fuertes AN. Diagnosis of isovaleric acidemia by tandem mass spectrometry: false positive result due to pivaloylcarnitine in a newborn screening programme. Journal of Inherited Metabolic Disease 1998; 21(6): 624-630.
– reference: Beaudette P and Bateman KP. Discovery stage pharmacokinetics using dried blood spots. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences. 2004; 809(1): 153-158.
– reference: Wamelink MM, Struys EA, Huck JH, Roos B, van der Knaap MS, Jakobs C and Verhoeven NM. Quantification of sugar phosphate intermediates of the pentose phosphate pathway by LC-MS/MS: application to two new inherited defects of metabolism. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2005; 823(1): 18-25.
– reference: Banta-Wright SA and Steiner RD. Tandem mass spectrometry in newborn screening: a primer for neonatal and perinatal nurses. Journal of Perinatal and Neonatal Nursing 2004; 18(1): 41-58.
– reference: la Marca G, Malvagia S, Pasquini E, Innocenti M, Donati MA and Zammarchi E. Rapid 2nd-tier test for measurement of 3-OH-propionic and methylmalonic acids on dried blood spots: reducing the false-positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography-tandem mass spectrometry. Clinical Chemistry 2007; 53(7): 1364-1369.
– reference: Al-Dirbashi OY, Rashed MS, Jacob M, Al-Ahaideb LY, Al-Amoudi M, Rahbeeni Z, Al-Sayed MM, Al-Hassnan Z, Al-Owain M and Al-Zeidan H. Improved method to determine succinylacetone in dried blood spots for diagnosis of tyrosinemia type 1 using UPLC-MS/MS. Biomedical Chromatography. 2008; 22(11): 1181-1185.
– reference: Alfazil AA and Anderson RA. Stability of benzodiazepines and cocaine in blood spots stored on filter paper. Journal of Analytical Toxicology. 2008; 32(7): 511-515.
– reference: Burhenne J, Riedel KD, Rengelshausen J, Meissner P, Müller O, Mikus G, Haefeli WE and Walter-Sack I. Quantification of cationic anti-malaria agent methylene blue in different human biological matrices using cation exchange chromatography coupled to tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2008; 863(2): 273-282.
– reference: Spooner N, Lad R and Barfield M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Analytical Chemistry 2009; 81(4): 1557-1563.
– reference: Déglon J, Thomas A, Cataldo A, Mangin P and Staub C. On-line desorption of dried blood spot: A novel approach for the direct LC/MS analysis of micro-whole blood samples. Journal of Pharmaceutical and Biomedical Analysis 2009; 49(4): 1034-1039.
– reference: Chace DH, Kalas TA and Naylor EW. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism. Annual Review of Genomics and Human Genetics 2002; 3: 17-45.
– reference: Damen CW, Rosing H, Schellens JH and Beijnen JH. Application of dried blood spots combined with high-performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry for simultaneous quantification of vincristine and actinomycin-D. Analytical and Bioanalytical Chemistry 2009; 394(4): 1171-1182.
– reference: McCann SJ, Gillingwater S, Keevil BG, Cooper DP and Morris MR. Measurement of total homocysteine in plasma and blood spots using liquid chromatography-tandem mass spectrometry: comparison with the plasma Abbott IMx method. Annals of Clinical Biochemistry 2003; 40(Pt 2): 161-165.
– reference: Yu HC, Tuteja S, Moon JI, Kleiner GI, Conanan L, Gaynor JJ, Kato T, Levi DM, Nishida S, Selvaggi G, Gandia C, Weppler D, Esquenazi V, Ruiz P, Miller J and Tzakis AG. Utilization of dried blood spot citrulline level as a noninvasive method for monitoring graft function following intestinal transplantation. Transplantation 2005; 80(12): 1729-1733.
– reference: Strnadová KA, Holub M, Mühl A, Heinze G, Ratschmann R, Mascher H, Stöckler-Ipsiroglu S, Waldhauser F, Votava F, Lebl J and Bodamer OA. Long-term stability of amino acids and acylcarnitines in dried blood spots. Clinical Chemistry 2007; 53(4): 717-722.
– reference: Minutti CZ, Lacey JM, Magera MJ, Hahn SH, McCann M, Schulze A, Cheillan D, Dorche C, Chace DH, Lymp JF, Zimmerman D, Rinaldo P and Matern D. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism 2004; 89(8): 3687-3693.
– reference: Wong T, Shackleton CH, Covey TR and Ellis G. Identification of the steroids in neonatal plasma that interfere with 17 alpha-hydroxyprogesterone radioimmunoassays. Clinical Chemistry. 1992; 38(9): 1830-1837.
– reference: Shigematsu Y, Hata I, Kikawa Y, Mayumi M, Tanaka Y, Sudo M and Kado N. Modifications in electrospray tandem mass spectrometry for a neonatal-screening pilot study in Japan. Journal of Chromatography B, Biomedical Sciences and Applications 1999; 731(1): 97-103.
– reference: Török D, Mühl A, Votava F, Heinze G, Sólyom J, Crone J, Stöckler-Ipsiroglu S and Waldhauser F. Stability of 17alpha-hydroxyprogesterone in dried blood spots after autoclaving and prolonged storage. Clinical Chemistry 2002; 48(2): 370-372.
– reference: Liang X, Li Y, Barfield M and Ji QC. Study of dried blood spots technique for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC-MS/MS. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2009; 877(8-9): 799-806.
– reference: Guthrie R and Suzi A. A Simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 1963; 32: 338-343.
– reference: Pang S, Hotchkiss J, Drash AL, Levine LS and New MI. Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. The Journal of Clinical Endocrinology and Metabolism 1977; 45(5): 1003-1008.
– reference: Garg U and Dasouki M. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects. Clinical Biochemistry 2006; 39(4): 315-332.
– reference: Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U and Sander J. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. The Journal of Clinical Endocrinology and Metabolism 2007; 92(7): 2581-2589.
– reference: Shigematsu Y, Hata I and Tanaka Y. Stable-isotope dilution measurement of isovalerylglycine by tandem mass spectrometry in newborn screening for isovaleric acidemia. Clinica Chimica Acta 2007; 386(1-2): 82-86.
– reference: Janzen N, Sander S, Terhardt M, Peter M and Sander J. Fast and direct quantification of adrenal steroids by tandem mass spectrometry in serum and dried blood spots. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2008; 861(1): 117-122.
– reference: Henderson LO, Powell MK, Hannon WH, Bernert JT Jr, Pass KA, Fernhoff P, Ferre CD, Martin L, Franko E, Rochat RW, Brantley MD and Sampson E. An evaluation of the use of dried blood spots from newborn screening for monitoring the prevalence of cocaine use among childbearing women. Biochemical and Molecular Medicine 1997; 61(2): 143-151.
– reference: Rinaldo P, Tortorelli S and Matern. Recent developments and new applications of tandem mass spectrometry in newborn screening. Current Opinion in Pediatrics 2004; 16(4): 427-433.
– reference: la Marca G, Malvagia S, Filippi L, Luceri F, Moneti G and Guerrini R. A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC-tandem mass spectrometry. Epilepsia 20 July 2009 (on-line).
– reference: Millington DS, Kodo N, Norwood DL and Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. Journal of Inherited Metabolic Disease 1990; 13(3): 321-324.
– reference: Lacey JM, Minutti CZ, Magera MJ, Tauscher AL, Casetta B, McCann M, Lymp J, Hahn SH, Rinaldo P and Matern D. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Clinical Chemistry 2004; 50(3): 621-625.
– reference: Holub M, Tuschl K, Ratschmann R, Strnadová KA, Mühl A, Heinze G, Sperl W and Bodamer OA. Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometry. Clinica Chimica Acta 2006; 373(1-2): 27-31.
– reference: ter Heine R, Rosing H, van Gorp EC, Mulder JW, Beijnen JH and Huitema AD. Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2009b; 49(2): 393-400.
– reference: la Marca G, Malvagia S, Filippi L, Fiorini P, Innocenti M, Luceri F, Pieraccini G, Moneti G, Francese S, Dani FR and Guerrini R. Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric method. Journal of Pharmaceutical and Biomedical Analysis 2008b; 48(5): 1392-1396.
– reference: Hoogtanders K, van der Heijden J, Christiaans M, Edelbroek P, van Hooff JP and Stolk LM. Therapeutic drug monitoring of tacrolimus with the dried blood spot method. Journal of Pharmaceutical and Biomedical Analysis 2007; 44(3): 658-664.
– reference: Lai CC, Tsai CH, Tsai FJ, Lee CC and Lin WD. Rapid monitoring assay of congenital adrenal hyperplasia with microbore high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots. Rapid Communications in Mass Spectrometry 2001; 15(22): 2145-2151.
– reference: Garcia Boy R, Henseler J, Mattern R and Skopp G. Determination of morphine and 6-acetylmorphine in blood with use of dried blood spots. Therapeutic Drug Monitoring 2008; 30(6): 733-739.
– reference: Sosnoff CS, Ann Q, Bernert JT Jr, Powell MK, Miller BB, Henderson LO, Hannon WH, Fernhoff P and Sampson EJ. Analysis of benzoylecgonine in dried blood spots by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry. Journal of Analytical Toxicology 1996; 20(3): 179-184.
– reference: ter Heine R, Rosing H, van Gorp EC, Mulder JW, Van Der Steeg WA, Beijnen JH and Huitema AD. Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2008; 867(2): 205-212.
– reference: Wilhelm AJ, den Burger JC, Vos RM, Chahbouni A and Sinjewel A. Analysis of cyclosporin A in dried blood spots using liquid chromatography tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2009; 877(14-15): 1595-1598.
– reference: Hubbard WC, Moser AB, Tortorelli S, Liu A, Jones D and Moser H. Combined liquid chromatography-tandem mass spectrometry as an analytical method for high throughput screening for X-linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings. Molecular Genetics and Metabolism 2006; 89(1-2): 185-187.
– reference: Piraud M, Vianey-Saban C, Petritis K, Elfakir C, Steghens JP, Morla A and Bouchu D. ESI-MS/MS analysis of underivatised amino acids: a new tool for the diagnosis of inherited disorders of amino acid metabolism. Fragmentation study of 79 molecules of biological interest in positive and negative ionisation mode. Rapid Communications in Mass Spectrometry 2003; 17(12): 1297-1311.
– reference: Newman MS, Brandon TR, Groves MN, Gregory WL, Kapur S and Zava DT. A liquid chromatography/Tandem mass spectrometry method for determination of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in dried blood spots: a potential adjunct to diabetes and cardiometabolic risk screening. Journal of Diabetes Science and Technology 2009; 3(1): 156-162.
– reference: Johnson DW and Trinh MU. Stability of malonylcarnitine and glutarylcarnitine in stored blood spots. Journal of Inherited Metabolic Disease 2004; 27(6): 789-790.
– reference: Oglesbee D, Sanders KA, Lacey JM, Magera MJ, Casetta B, Strauss KA, Tortorelli S, Rinaldo P and Matern D. Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD). Clinical Chemistry 2008; 54(3): 542-549.
– reference: Higashi T, Nishio T, Uchida S, Shimada K, Fukushi M and Maeda M. Simultaneous determination of 17α-hydroxypregnenolone and 17α-hydroxyprogesterone in dried blood spots from low birth weight infants using LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis 2008; 48(1): 177-182.
– reference: Hubbard WC, Moser AB, Liu AC, Jones RO, Steinberg SJ, Lorey F, Panny SR, Vogt RF Jr, Macaya D, Turgeon CT, Tortorelli S and Raymond GV. Newborn screening for X-linked adrenoleukodystrophy (X-ALD): validation of a combined liquid chromatography-tandem mass spectrometric (LC-MS/MS) method. Molecular Genetics and Metabolism 2009; 97(3): 212-220.
– reference: ter Heine R, Hillebrand MJ, Rosing H, van Gorp EC, Mulder JW, Beijnen JH and Huitema AD. Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2009a; 49(2): 451-458.
– reference: Eyles D, anderson C, Ko P, Jones A, Thomas A, Burne T, Mortensen PB, Nørgaard-Pedersen B, Hougaard DM and McGrath J. A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. Clinica Chimica Acta 2009; 403(1-2): 145-151.
– reference: McDade TW, Williams S and Snodgrass JJ. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 2007; 44(4): 899-925.
– reference: Chace DH, Hillman SL, Millington DS, Kahler SG, Roe CR and Naylor EW. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry. Clinical Chemistry 1995; 41(1): 62-68.
– reference: Deng C, Ji J, Zhang L and Zhang X. Diagnosis of congenital adrenal hyperplasia by rapid determination of 17alpha-hydroxyprogesterone in dried blood spots by gas chromatography/mass spectrometry following microwave-assisted silylation. Rapid Communications in Mass Spectrometry 2005; 19(20): 2974-2978.
– reference: O'Broin SD, Kelleher BP and Gunter E. Evaluation of factors influencing precision in the analysis of samples taken from blood spots on filter paper. Clinical and Laboratory Haematology 1995; 17(2): 185-188.
– reference: Wilcken B and Wiley V. Newborn screening. Pathology, 2008; 40(2): 104-105.
– reference: Kayiran SM, Ozbek N, Turan M and Gürakan B. Significant differences between capillary and venous complete blood counts in the neonatal period. Clinical and Laboratory Haematology 2003; 25(1): 9-16.
– reference: Chen J and Hsieh Y. Stabilizing drug molecules in biological samples. Therapeutic Drug Monitoring 2005; 27(5): 617-624.
– reference: Edelbroek PM, van der Heijden J and Stolk LM. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls. Therapeutic Drug Monitoring 2009; 31(3): 327-336.
– reference: Zoppa M, Gallo L, Zacchello F and Giordano G. Method for the quantification of underivatized amino acids on dry blood spots from newborn screening by HPLC-ESI-MS/MS. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2006; 831(1-2): 267-273.
– reference: Koal T, Burhenne H, Römling R, Svoboda M, Resch K and Kaever V. Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2005; 19(21): 2995-3001.
– reference: Fingerhut R, Ensenauer R, Röschinger W, Arnecke R, Olgemöller B and Roscher AA. Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency. Analytical Chemistry 2009; 81(9): 3571-3575.
– reference: Chace DH, Kalas TA and Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns. Clinical Chemistry 2003; 49(11): 1797-1817.
– reference: Schulze A, Schmidt C, Kohlmüller D, Hoffmann GF and Mayatepek E. Accurate measurement of free carnitine in dried blood spots by isotope-dilution electrospray tandem mass spectrometry without butylation. Clinica Chimica Acta 2003; 335(1-2): 137-145.
– reference: Barfield M, Spooner N, Lad R, Parry S and Fowles S. Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2008; 870(1): 32-37.
– reference: la Marca G, Malvagia S, Casetta B, Pasquini E, Donati MA and Zammarchi E. Progress in expanded newborn screening for metabolic conditions by LC-MS/MS in Tuscany: update on methods to reduce false tests. Journal of Inherited Metabolic Disease Short report no. 127, 2008a.
– reference: Al-Dirbashi OY, Rashed MS, Brink HJ, Jakobs C, Filimban N, Al-Ahaidib LY, Jacob M, Al-Sayed MM, Al-Hassnan Z and Faqeih E. Determination of succinylacetone in dried blood spots and liquid urine as a dansylhydrazone by liquid chromatography tandem mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2006; 831(1-2): 274-280.
– reference: Huck JH, Struys EA, Verhoeven NM, Jakobs C and van der Knaap MS. Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass spectrometry: application to transaldolase deficiency. Clinical Chemistry 2003; 49(8): 1375-1380.
– reference: Mei JV, Alexander JR, Adam BW and Hannon WH. Use of filter paper for the collection and analysis of human whole blood specimens. Journal of Nutrition 2001; 131(5): 1631S-1636S.
– reference: Carpenter KH and Wiley V. Application of tandem mass spectrometry to biochemical genetics and newborn screening. Clinica Chimica Acta 2002; 322(1-2): 1-10.
– volume: 61
  start-page: 143
  issue: 2
  year: 1997
  end-page: 151
  article-title: An evaluation of the use of dried blood spots from newborn screening for monitoring the prevalence of cocaine use among childbearing women
  publication-title: Biochemical and Molecular Medicine
– volume: 16
  start-page: 20
  issue: 1
  year: 2002
  end-page: 25
  article-title: Rapid screening assay of congenital adrenal hyperplasia by measuring 17 ‐hydroxyprogesterone with high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots
  publication-title: Journal of Clinical Laboratory Analysis
– volume: 17
  start-page: 1297
  issue: 12
  year: 2003
  end-page: 1311
  article-title: ESI‐MS/MS analysis of underivatised amino acids: a new tool for the diagnosis of inherited disorders of amino acid metabolism. Fragmentation study of 79 molecules of biological interest in positive and negative ionisation mode
  publication-title: Rapid Communications in Mass Spectrometry
– volume: 32
  start-page: 511
  issue: 7
  year: 2008
  end-page: 515
  article-title: Stability of benzodiazepines and cocaine in blood spots stored on filter paper
  publication-title: Journal of Analytical Toxicology
– year: 2009
  article-title: A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC‐tandem mass spectrometry
  publication-title: Epilepsia
– volume: 40
  start-page: 104
  issue: 2
  year: 2008
  end-page: 105
  article-title: Newborn screening
  publication-title: Pathology
– volume: 877
  start-page: 1595
  issue: 14–15
  year: 2009
  end-page: 1598
  article-title: Analysis of cyclosporin A in dried blood spots using liquid chromatography tandem mass spectrometry
  publication-title: Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences
– volume: 41
  start-page: 62
  issue: 1
  year: 1995
  end-page: 68
  article-title: Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry
  publication-title: Clinical Chemistry
– year: 2001
– volume: 88
  start-page: 16
  issue: 1
  year: 2006
  end-page: 21
  article-title: Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I
  publication-title: Molecular Genetics and Metabolism
– volume: 19
  start-page: 2974
  issue: 20
  year: 2005
  end-page: 2978
  article-title: Diagnosis of congenital adrenal hyperplasia by rapid determination of 17alpha‐hydroxyprogesterone in dried blood spots by gas chromatography/mass spectrometry following microwave‐assisted silylation
  publication-title: Rapid Communications in Mass Spectrometry
– volume: 870
  start-page: 32
  issue: 1
  year: 2008
  end-page: 37
  article-title: Application of dried blood spots combined with HPLC‐MS/MS for the quantification of acetaminophen in toxicokinetic studies
  publication-title: Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences
– volume: 30
  start-page: 733
  issue: 6
  year: 2008
  end-page: 739
  article-title: Determination of morphine and 6‐acetylmorphine in blood with use of dried blood spots
  publication-title: Therapeutic Drug Monitoring
– volume: 30
  start-page: 387
  issue: 3
  year: 2007
  end-page: 395
  article-title: Two step derivatization for the analyses of organic, amino acids and glycines on filter paper plasma by GC‐MS/SIM
  publication-title: Archives of Pharmaceutical Research
– volume: 40
  start-page: 161
  issue: Pt 2
  year: 2003
  end-page: 165
  article-title: Measurement of total homocysteine in plasma and blood spots using liquid chromatography–tandem mass spectrometry: comparison with the plasma Abbott IMx method
  publication-title: Annals of Clinical Biochemistry
– volume: 322
  start-page: 1
  issue: 1–2
  year: 2002
  end-page: 10
  article-title: Application of tandem mass spectrometry to biochemical genetics and newborn screening
  publication-title: Clinica Chimica Acta
– volume: 21
  start-page: 140
  issue: 2
  year: 2008
  end-page: 145
  article-title: Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation
  publication-title: Transplant International
– volume: 49
  start-page: 1375
  issue: 8
  year: 2003
  end-page: 1380
  article-title: Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass spectrometry: application to transaldolase deficiency
  publication-title: Clinical Chemistry
– volume: 52
  start-page: 633
  year: 1999
  end-page: 639
  article-title: The use of the dried blood spot samples in epidemiological studies
  publication-title: Journal of Clinical Pathology
– volume: 50
  start-page: 664
  issue: 4
  year: 2009
  end-page: 670
  article-title: Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography–mass spectrometry
  publication-title: Journal of Pharmaceutical and Biomedical Analysis
– volume: 20
  start-page: 179
  issue: 3
  year: 1996
  end-page: 184
  article-title: Analysis of benzoylecgonine in dried blood spots by liquid chromatography–atmospheric pressure chemical ionization tandem mass spectrometry
  publication-title: Journal of Analytical Toxicology
– volume: 16
  start-page: 427
  issue: 4
  year: 2004
  end-page: 433
  article-title: Recent developments and new applications of tandem mass spectrometry in newborn screening
  publication-title: Current Opinion in Pediatrics
– year: 2008a
  article-title: Progress in expanded newborn screening for metabolic conditions by LC‐MS/MS in Tuscany: update on methods to reduce false tests
  publication-title: Journal of Inherited Metabolic Disease
– volume: 809
  start-page: 153
  issue: 1
  year: 2004
  end-page: 158
  article-title: Discovery stage pharmacokinetics using dried blood spots
  publication-title: Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences
– volume: 31
  start-page: 327
  issue: 3
  year: 2009
  end-page: 336
  article-title: Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls
  publication-title: Therapeutic Drug Monitoring
– volume: 13
  start-page: 321
  issue: 3
  year: 1990
  end-page: 324
  article-title: Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism
  publication-title: Journal of Inherited Metabolic Disease
– volume: 823
  start-page: 18
  issue: 1
  year: 2005
  end-page: 25
  article-title: Quantification of sugar phosphate intermediates of the pentose phosphate pathway by LC‐MS/MS: application to two new inherited defects of metabolism
  publication-title: Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences
– volume: 17
  start-page: 185
  issue: 2
  year: 1995
  end-page: 188
  article-title: Evaluation of factors influencing precision in the analysis of samples taken from blood spots on filter paper
  publication-title: Clinical and Laboratory Haematology
– volume: 81
  start-page: 1557
  issue: 4
  year: 2009
  end-page: 1563
  article-title: Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method
  publication-title: Analytical Chemistry
– volume: 861
  start-page: 117
  issue: 1
  year: 2008
  end-page: 122
  article-title: Fast and direct quantification of adrenal steroids by tandem mass spectrometry in serum and dried blood spots
  publication-title: Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences
– volume: 38
  start-page: 1830
  issue: 9
  year: 1992
  end-page: 1837
  article-title: Identification of the steroids in neonatal plasma that interfere with 17 alpha‐hydroxyprogesterone radioimmunoassays
  publication-title: Clinical Chemistry
– year: 2008
– volume: 831
  start-page: 267
  issue: 1–2
  year: 2006
  end-page: 273
  article-title: Method for the quantification of underivatized amino acids on dry blood spots from newborn screening by HPLC‐ESI‐MS/MS
  publication-title: Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences
– year: 1997
– volume: 89
  start-page: 185
  issue: 1–2
  year: 2006
  end-page: 187
  article-title: Combined liquid chromatography–tandem mass spectrometry as an analytical method for high throughput screening for X‐linked adrenoleukodystrophy and other peroxisomal disorders: preliminary findings
  publication-title: Molecular Genetics and Metabolism
– volume: 53
  start-page: 1364
  issue: 7
  year: 2007
  end-page: 1369
  article-title: Rapid 2nd‐tier test for measurement of 3‐OH‐propionic and methylmalonic acids on dried blood spots: reducing the false‐positive rate for propionylcarnitine during expanded newborn screening by liquid chromatography–tandem mass spectrometry
  publication-title: Clinical Chemistry
– volume: 48
  start-page: 1392
  issue: 5
  year: 2008b
  end-page: 1396
  article-title: Rapid assay of topiramate in dried blood spots by a new liquid chromatography–tandem mass spectrometric method
  publication-title: Journal of Pharmaceutical and Biomedical Analysis
– volume: 863
  start-page: 273
  issue: 2
  year: 2008
  end-page: 282
  article-title: Quantification of cationic anti‐malaria agent methylene blue in different human biological matrices using cation exchange chromatography coupled to tandem mass spectrometry
  publication-title: Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences
– volume: 731
  start-page: 97
  issue: 1
  year: 1999
  end-page: 103
  article-title: Modifications in electrospray tandem mass spectrometry for a neonatal‐screening pilot study in Japan
  publication-title: Journal of Chromatography B, Biomedical Sciences and Applications
– volume: 49
  start-page: 451
  issue: 2
  year: 2009a
  end-page: 458
  article-title: Quantification of the HIV‐integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high‐performance liquid chromatography tandem mass spectrometry
  publication-title: Journal of Pharmaceutical and Biomedical Analysis
– volume: 393
  start-page: 1481
  issue: 5
  year: 2009
  end-page: 1497
  article-title: Newborn screening for inborn errors of metabolism and endocrinopathies: an update
  publication-title: Analytical and Bioanalytical Chemistry
– volume: 48
  start-page: 370
  issue: 2
  year: 2002
  end-page: 372
  article-title: Stability of 17alpha‐hydroxyprogesterone in dried blood spots after autoclaving and prolonged storage
  publication-title: Clinical Chemistry
– volume: 80
  start-page: 1729
  issue: 12
  year: 2005
  end-page: 1733
  article-title: Utilization of dried blood spot citrulline level as a noninvasive method for monitoring graft function following intestinal transplantation
  publication-title: Transplantation
– volume: 54
  start-page: 542
  issue: 3
  year: 2008
  end-page: 549
  article-title: Second‐tier test for quantification of alloisoleucine and branched‐chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD)
  publication-title: Clinical Chemistry
– volume: 44
  start-page: 899
  issue: 4
  year: 2007
  end-page: 925
  article-title: What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population‐based research
  publication-title: Demography
– volume: 49
  start-page: 1797
  issue: 11
  year: 2003
  end-page: 1817
  article-title: Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns
  publication-title: Clinical Chemistry
– volume: 30
  start-page: 585
  issue: 4
  year: 2007
  end-page: 592
  article-title: Reduction of the false‐positive rate in newborn screening by implementation of MS/MS‐based second‐tier tests: the Mayo Clinic experience (2004–2007)
  publication-title: Journal of Inherited Metabolic Disease
– volume: 53
  start-page: 717
  issue: 4
  year: 2007
  end-page: 722
  article-title: Long‐term stability of amino acids and acylcarnitines in dried blood spots
  publication-title: Clinical Chemistry
– volume: 403
  start-page: 145
  issue: 1–2
  year: 2009
  end-page: 151
  article-title: A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots
  publication-title: Clinica Chimica Acta
– volume: 131
  start-page: 1631S
  issue: 5
  year: 2001
  end-page: 1636S
  article-title: Use of filter paper for the collection and analysis of human whole blood specimens
  publication-title: Journal of Nutrition
– volume: 45
  start-page: 1003
  issue: 5
  year: 1977
  end-page: 1008
  article-title: Microfilter paper method for 17 alpha‐hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia
  publication-title: The Journal of Clinical Endocrinology and Metabolism
– volume: 97
  start-page: 212
  issue: 3
  year: 2009
  end-page: 220
  article-title: Newborn screening for X‐linked adrenoleukodystrophy (X‐ALD): validation of a combined liquid chromatography–tandem mass spectrometric (LC‐MS/MS) method
  publication-title: Molecular Genetics and Metabolism
– volume: 831
  start-page: 274
  issue: 1–2
  year: 2006
  end-page: 280
  article-title: Determination of succinylacetone in dried blood spots and liquid urine as a dansylhydrazone by liquid chromatography tandem mass spectrometry
  publication-title: Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences
– volume: 92
  start-page: 2581
  issue: 7
  year: 2007
  end-page: 2589
  article-title: Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography–tandem mass spectrometry
  publication-title: The Journal of Clinical Endocrinology and Metabolism
– volume: 46
  start-page: 126
  issue: 1
  year: 2000
  end-page: 128
  article-title: Recoveries of phenylalanine from two sets of dried‐blood‐spot reference materials: prediction from hematocrit, spot volume, and paper matrix
  publication-title: Clinical Chemistry
– volume: 3
  start-page: 17
  year: 2002
  end-page: 45
  article-title: The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism
  publication-title: Annual Review of Genomics and Human Genetics
– volume: 27
  start-page: 789
  issue: 6
  year: 2004
  end-page: 790
  article-title: Stability of malonylcarnitine and glutarylcarnitine in stored blood spots
  publication-title: Journal of Inherited Metabolic Disease
– volume: 74
  start-page: 662
  issue: 8
  year: 2009
  end-page: 5
  article-title: False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)‐ether extraction reveals two distinct reasons for elevated 17alpha‐hydroxyprogesterone (17‐OHP) values
  publication-title: Steroids
– volume: 46
  start-page: 122
  issue: 1
  year: 2000
  end-page: 123
  article-title: Rapid determination of total homocysteine in blood spots by liquid chromatography–electrospray ionization–tandem mass spectrometry
  publication-title: Clinical Chemistry
– volume: 22
  start-page: 1181
  issue: 11
  year: 2008
  end-page: 1185
  article-title: Improved method to determine succinylacetone in dried blood spots for diagnosis of tyrosinemia type 1 using UPLC‐MS/MS
  publication-title: Biomedical Chromatography
– volume: 44
  start-page: 658
  issue: 3
  year: 2007
  end-page: 664
  article-title: Therapeutic drug monitoring of tacrolimus with the dried blood spot method
  publication-title: Journal of Pharmaceutical and Biomedical Analysis
– volume: 394
  start-page: 1171
  issue: 4
  year: 2009
  end-page: 1182
  article-title: Application of dried blood spots combined with high‐performance liquid chromatography coupled with electrospray ionisation tandem mass spectrometry for simultaneous quantification of vincristine and actinomycin‐D
  publication-title: Analytical and Bioanalytical Chemistry
– volume: 48
  start-page: 177
  issue: 1
  year: 2008
  end-page: 182
  article-title: Simultaneous determination of 17 ‐hydroxypregnenolone and 17 ‐hydroxyprogesterone in dried blood spots from low birth weight infants using LC‐MS/MS
  publication-title: Journal of Pharmaceutical and Biomedical Analysis
– volume: 867
  start-page: 205
  issue: 2
  year: 2008
  end-page: 212
  article-title: Quantification of protease inhibitors and non‐nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography–triple quadrupole mass spectrometry
  publication-title: Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences
– volume: 18
  start-page: 41
  issue: 1
  year: 2004
  end-page: 58
  article-title: Tandem mass spectrometry in newborn screening: a primer for neonatal and perinatal nurses
  publication-title: Journal of Perinatal and Neonatal Nursing
– volume: 3
  start-page: 156
  issue: 1
  year: 2009
  end-page: 162
  article-title: A liquid chromatography/Tandem mass spectrometry method for determination of 25‐hydroxy vitamin D and 25‐hydroxy vitamin D3 in dried blood spots: a potential adjunct to diabetes and cardiometabolic risk screening
  publication-title: Journal of Diabetes Science and Technology
– volume: 15
  start-page: 2145
  issue: 22
  year: 2001
  end-page: 2151
  article-title: Rapid monitoring assay of congenital adrenal hyperplasia with microbore high‐performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots
  publication-title: Rapid Communications in Mass Spectrometry
– volume: 373
  start-page: 27
  issue: 1–2
  year: 2006
  end-page: 31
  article-title: Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometry
  publication-title: Clinica Chimica Acta
– volume: 19
  start-page: 2995
  issue: 21
  year: 2005
  end-page: 3001
  article-title: Quantification of antiretroviral drugs in dried blood spot samples by means of liquid chromatography/tandem mass spectrometry
  publication-title: Rapid Communications in Mass Spectrometry
– volume: 39
  start-page: 315
  issue: 4
  year: 2006
  end-page: 332
  article-title: Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspects
  publication-title: Clinical Biochemistry
– volume: 32
  start-page: 338
  year: 1963
  end-page: 343
  article-title: Simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants
  publication-title: Pediatrics
– volume: 49
  start-page: 393
  issue: 2
  year: 2009b
  end-page: 400
  article-title: Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry
  publication-title: Journal of Pharmaceutical and Biomedical Analysis
– volume: 335
  start-page: 137
  issue: 1–2
  year: 2003
  end-page: 145
  article-title: Accurate measurement of free carnitine in dried blood spots by isotope‐dilution electrospray tandem mass spectrometry without butylation
  publication-title: Clinica Chimica Acta
– volume: 27
  start-page: 617
  issue: 5
  year: 2005
  end-page: 624
  article-title: Stabilizing drug molecules in biological samples
  publication-title: Therapeutic Drug Monitoring
– volume: 22
  start-page: 812
  issue: 6
  year: 2008c
  end-page: 818
  article-title: The inclusion of succinylacetone as marker for tyrosinemia type I in expanded newborn screening programs
  publication-title: Rapid Communications in Mass Spectrometry
– volume: 386
  start-page: 82
  issue: 1–2
  year: 2007
  end-page: 86
  article-title: Stable‐isotope dilution measurement of isovalerylglycine by tandem mass spectrometry in newborn screening for isovaleric acidemia
  publication-title: Clinica Chimica Acta
– volume: 81
  start-page: 3571
  issue: 9
  year: 2009
  end-page: 3575
  article-title: Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency
  publication-title: Analytical Chemistry
– volume: 89
  start-page: 3687
  issue: 8
  year: 2004
  end-page: 3693
  article-title: Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia
  publication-title: The Journal of Clinical Endocrinology and Metabolism
– volume: 39
  start-page: 66
  issue: 1
  year: 1993
  end-page: 71
  article-title: Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry
  publication-title: Clinical Chemistry
– volume: 39
  start-page: 1354
  issue: 6
  year: 1993
  end-page: 1355
  article-title: Influence of hematocrit on quantitative analysis of ‘blood spots’ on filter paper
  publication-title: Clinical Chemistry
– volume: 877
  start-page: 799
  issue: 8–9
  year: 2009
  end-page: 806
  article-title: Study of dried blood spots technique for the determination of dextromethorphan and its metabolite dextrorphan in human whole blood by LC‐MS/MS
  publication-title: Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences
– volume: 25
  start-page: 9
  issue: 1
  year: 2003
  end-page: 16
  article-title: Significant differences between capillary and venous complete blood counts in the neonatal period
  publication-title: Clinical and Laboratory Haematology
– volume: 49
  start-page: 1034
  issue: 4
  year: 2009
  end-page: 1039
  article-title: On‐line desorption of dried blood spot: A novel approach for the direct LC/MS analysis of micro‐whole blood samples
  publication-title: Journal of Pharmaceutical and Biomedical Analysis
– volume: 21
  start-page: 624
  issue: 6
  year: 1998
  end-page: 630
  article-title: Diagnosis of isovaleric acidemia by tandem mass spectrometry: false positive result due to pivaloylcarnitine in a newborn screening programme
  publication-title: Journal of Inherited Metabolic Disease
– volume: 50
  start-page: 621
  issue: 3
  year: 2004
  end-page: 625
  article-title: Improved specificity of newborn screening for congenital adrenal hyperplasia by second‐tier steroid profiling using tandem mass spectrometry
  publication-title: Clinical Chemistry
– ident: e_1_2_1_76_1
  doi: 10.1016/j.jpba.2008.10.040
– ident: e_1_2_1_8_1
  doi: 10.1016/j.jchromb.2008.05.025
– ident: e_1_2_1_39_1
  doi: 10.1210/jc.2006-2890
– ident: e_1_2_1_40_1
  doi: 10.1016/j.jchromb.2007.11.006
– ident: e_1_2_1_20_1
  doi: 10.1002/rcm.2163
– ident: e_1_2_1_69_1
  doi: 10.1016/S0378-4347(99)00111-5
– ident: e_1_2_1_52_1
  doi: 10.1016/j.jchromb.2009.02.015
– ident: e_1_2_1_64_1
  doi: 10.1210/jcem-45-5-1003
– ident: e_1_2_1_63_1
  doi: 10.1373/clinchem.2007.098434
– ident: e_1_2_1_4_1
  doi: 10.1016/j.jchromb.2005.12.010
– ident: e_1_2_1_21_1
  doi: 10.1097/FTD.0b013e31819e91ce
– ident: e_1_2_1_24_1
  doi: 10.1016/j.steroids.2009.02.008
– ident: e_1_2_1_62_1
  doi: 10.1111/j.1365-2257.1995.tb01230.x
– ident: e_1_2_1_9_1
  doi: 10.1016/j.jchromb.2004.06.018
– volume: 38
  start-page: 1830
  issue: 9
  year: 1992
  ident: e_1_2_1_83_1
  article-title: Identification of the steroids in neonatal plasma that interfere with 17 alpha‐hydroxyprogesterone radioimmunoassays
  publication-title: Clinical Chemistry
  doi: 10.1093/clinchem/38.9.1830
– ident: e_1_2_1_46_1
  doi: 10.1002/jcla.2039
– ident: e_1_2_1_17_1
  doi: 10.1111/j.1432-2277.2007.00584.x
– ident: e_1_2_1_50_1
  doi: 10.1002/rcm.3428
– ident: e_1_2_1_66_1
  doi: 10.1002/rcm.1054
– ident: e_1_2_1_73_1
  doi: 10.1373/clinchem.2006.076679
– ident: e_1_2_1_85_1
  doi: 10.1097/01.tp.0000188168.45003.63
– ident: e_1_2_1_41_1
  doi: 10.1023/B:BOLI.0000045830.82698.90
– ident: e_1_2_1_42_1
  doi: 10.1046/j.1365-2257.2003.00484.x
– ident: e_1_2_1_2_1
  doi: 10.1023/A:1005424331822
– ident: e_1_2_1_14_1
  doi: 10.1146/annurev.genom.3.022502.103213
– ident: e_1_2_1_25_1
  doi: 10.1007/s00216-008-2505-y
– ident: e_1_2_1_33_1
  doi: 10.1016/j.jpba.2008.05.010
– volume: 46
  start-page: 122
  issue: 1
  year: 2000
  ident: e_1_2_1_29_1
  article-title: Rapid determination of total homocysteine in blood spots by liquid chromatography–electrospray ionization–tandem mass spectrometry
  publication-title: Clinical Chemistry
  doi: 10.1093/clinchem/46.1.122
– ident: e_1_2_1_81_1
  doi: 10.1080/00313020701813743
– volume: 32
  start-page: 338
  year: 1963
  ident: e_1_2_1_30_1
  article-title: Simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants
  publication-title: Pediatrics
  doi: 10.1542/peds.32.3.338
– ident: e_1_2_1_56_1
  doi: 10.1353/dem.2007.0038
– ident: e_1_2_1_38_1
  doi: 10.1373/49.8.1375
– ident: e_1_2_1_67_1
  doi: 10.1097/01.mop.0000133635.79661.84
– ident: e_1_2_1_59_1
  doi: 10.1210/jc.2003-032235
– ident: e_1_2_1_51_1
  doi: 10.1111/j.1528-1167.2009.02204.x
– ident: e_1_2_1_75_1
  doi: 10.1016/j.jpba.2008.11.025
– ident: e_1_2_1_78_1
– ident: e_1_2_1_86_1
  doi: 10.1016/j.jchromb.2005.12.015
– ident: e_1_2_1_71_1
  doi: 10.1093/jat/20.3.179
– ident: e_1_2_1_54_1
  doi: 10.1007/s10545-007-0691-y
– ident: e_1_2_1_57_1
  doi: 10.1093/jn/131.5.1631S
– volume: 48
  start-page: 370
  issue: 2
  year: 2002
  ident: e_1_2_1_77_1
  article-title: Stability of 17alpha‐hydroxyprogesterone in dried blood spots after autoclaving and prolonged storage
  publication-title: Clinical Chemistry
  doi: 10.1093/clinchem/48.2.370
– ident: e_1_2_1_44_1
  doi: 10.1373/clinchem.2003.027193
– volume: 39
  start-page: 1354
  issue: 6
  year: 1993
  ident: e_1_2_1_61_1
  article-title: Influence of hematocrit on quantitative analysis of ‘blood spots’ on filter paper
  publication-title: Clinical Chemistry
  doi: 10.1093/clinchem/39.6.1354
– ident: e_1_2_1_80_1
  doi: 10.1016/j.jchromb.2005.01.001
– ident: e_1_2_1_7_1
  doi: 10.1097/00005237-200401000-00005
– ident: e_1_2_1_70_1
  doi: 10.1016/j.cca.2007.08.003
– volume: 39
  start-page: 66
  issue: 1
  year: 1993
  ident: e_1_2_1_12_1
  article-title: Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry
  publication-title: Clinical Chemistry
  doi: 10.1093/clinchem/39.1.66
– ident: e_1_2_1_27_1
  doi: 10.1097/FTD.0b013e31818d9fdb
– ident: e_1_2_1_37_1
  doi: 10.1016/j.ymgme.2009.03.010
– ident: e_1_2_1_45_1
  doi: 10.1002/rcm.493
– ident: e_1_2_1_36_1
  doi: 10.1016/j.ymgme.2006.05.001
– ident: e_1_2_1_35_1
  doi: 10.1016/j.jpba.2006.11.023
– ident: e_1_2_1_68_1
  doi: 10.1016/S0009-8981(03)00292-4
– ident: e_1_2_1_6_1
  doi: 10.1093/jat/32.7.511
– ident: e_1_2_1_18_1
  doi: 10.1007/s00216-009-2775-z
– ident: e_1_2_1_26_1
  doi: 10.1021/ac8022235
– ident: e_1_2_1_10_1
  doi: 10.1016/j.jchromb.2008.01.028
– ident: e_1_2_1_79_1
  doi: 10.1016/j.jpba.2008.11.021
– volume: 41
  start-page: 62
  issue: 1
  year: 1995
  ident: e_1_2_1_13_1
  article-title: Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry
  publication-title: Clinical Chemistry
  doi: 10.1093/clinchem/41.1.62
– ident: e_1_2_1_31_1
– ident: e_1_2_1_58_1
  doi: 10.1007/BF01799385
– ident: e_1_2_1_60_1
  doi: 10.1177/193229680900300118
– ident: e_1_2_1_49_1
  doi: 10.1016/j.jpba.2008.09.025
– ident: e_1_2_1_48_1
  doi: 10.1007/s10545-008-0965-z
– ident: e_1_2_1_53_1
  doi: 10.1016/j.ymgme.2005.12.005
– ident: e_1_2_1_15_1
  doi: 10.1373/clinchem.2003.022178
– ident: e_1_2_1_84_1
  doi: 10.1007/BF02977623
– volume: 46
  start-page: 126
  issue: 1
  year: 2000
  ident: e_1_2_1_3_1
  article-title: Recoveries of phenylalanine from two sets of dried‐blood‐spot reference materials: prediction from hematocrit, spot volume, and paper matrix
  publication-title: Clinical Chemistry
  doi: 10.1093/clinchem/46.1.126
– ident: e_1_2_1_19_1
  doi: 10.1016/j.jpba.2009.02.001
– ident: e_1_2_1_22_1
– ident: e_1_2_1_72_1
  doi: 10.1021/ac8022839
– ident: e_1_2_1_82_1
  doi: 10.1016/j.jchromb.2009.03.024
– ident: e_1_2_1_34_1
  doi: 10.1016/j.cca.2006.04.013
– ident: e_1_2_1_43_1
  doi: 10.1002/rcm.2158
– ident: e_1_2_1_74_1
  doi: 10.1016/j.jchromb.2008.04.003
– ident: e_1_2_1_32_1
  doi: 10.1006/bmme.1997.2609
– ident: e_1_2_1_5_1
  doi: 10.1002/bmc.1049
– ident: e_1_2_1_11_1
  doi: 10.1016/S0009-8981(02)00135-3
– ident: e_1_2_1_28_1
  doi: 10.1016/j.clinbiochem.2005.12.009
– ident: e_1_2_1_55_1
  doi: 10.1258/000456303763046094
– ident: e_1_2_1_16_1
  doi: 10.1097/01.ftd.0000170879.18139.40
– ident: e_1_2_1_65_1
  doi: 10.1136/jcp.52.9.633
– ident: e_1_2_1_47_1
  doi: 10.1373/clinchem.2007.087775
– ident: e_1_2_1_23_1
  doi: 10.1016/j.cca.2009.02.005
SSID ssj0009627
Score 2.4359558
SecondaryResourceType review_article
Snippet The collection of whole blood samples on paper, known as dried blood spot (DBS), dates back to the early 1960s in newborn screening for inherited metabolic...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 49
SubjectTerms Analytic Sample Preparation Methods
Blood Chemical Analysis - methods
Blood Specimen Collection
Chromatography, Liquid - methods
DBS
dried blood spot(s)
Drug Monitoring
Humans
LC-MS/MS
newborn screening
pharmacokinetics
quantitative analysis
Sensitivity and Specificity
small molecules
Tandem Mass Spectrometry - methods
therapeutic drug monitoring
toxicokinetics
Title Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules
URI https://api.istex.fr/ark:/67375/WNG-8PRFJQLT-3/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fbmc.1367
https://www.ncbi.nlm.nih.gov/pubmed/20017122
https://www.proquest.com/docview/734203534
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwELVQkYAXLlsuy02DhMpTulvbSdaPZWGpqqaCXkQlHizbcRDqbhaaXQl44hP4Rr6EGTvZqqhIiKdEyiTxZZwcj4_PMPZ8q6xSMVR5klfeJFKWWaIQFiRl5fAcIXsZVkyL_WznWO6epCctq5L2wkR9iFXAjUZG-F7TADe2GZyLhtqZI44WbSQnqhbhoYNz5SjKKRPDK4rkY1WnOzvkg-7GC3-iq9SoXy-DmRdRa_jtTG6xD12BI9vkdHO5sJvu-x9ajv9Xo9vsZotGYTu6zx12xdc9tr5d40x89g02IPBDQ-C9x66Pu9xwPXataJfk15l_hZPtEgIBHnCOvIDGEEu9_gifasAi4NQ79D5QyBf2xr9-_CwOB8UhIFyGL0tTh21u-NEF0wqkwLyCZmamU5jF5L2-ucuOJ6-PxjtJm7shcYi4sOuty7C3czmqpJCW2y0hucvKUggu8rTKhJPKS59R3g0vuHGK89JYKyuHEEWJe2ytntf-AQPBc5-PvLSVV1KmeDlVNksNGg2FyX2fvej6UbtW2Jzya0x1lGTmGhtWU8P22bOV5eco5nGJzUZwhZWBOTsl8lue6vf7b_To7cFk993ekRZ9Bp2vaGx9WmcxtZ8vG51jVYdYLdln96MPrR7Ggz4R5_iW4Al_LYZ-WYzp-PBfDR-xG5HYQNGhx2xtcbb0TxAvLezTMDJ-Ay5-EGw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD4am8R44dIBK1cjofGUtbOduBZPo6OU0VSwddoekCzbcSa0NoW1lYAnfgK_kV_CsZN0GhoS4imRcpL4cmx_5_j4OwDPd7I8Zm0pIpE7HXGeJZFEWBBlucV7hOxZ2DFNh0n_iO-fxCcr8LI-C1PyQywdbn5khPnaD3DvkG5dsIaaifVBWuIarPmE3j59wd7BBXeUzypTOlikJ5CVNfNsm7bqNy-tRWu-Wb9eBTQv49aw8PRuwce6yGW8ydn2Ym627fc_2Bz_s0634WYFSMluqUF3YMUVDdjYLdAYn3wjWySEiAbfewPWu3V6uAZcT6td-Q1we2hvZyTEwBM0k-dkpn2genFKPhUEy4DWd1AA4r2-ZND99eNnethKDwkiZvJloYtw0g3nXaIrjhQyzclsosdjMinz97rZXTjqvR51-1GVviGyCLqw941NsMMF7-SccUPNDuPUJlnGGGUizhNmuXTcJT71hmNUW0lppo3huUWUItk9WC2mhdsEwqhwouO4yZ3kPMbHsTRJrFGozbRwTXhRd6SyFbe5T7ExViUrM1XYsMo3bBOeLSU_l3weV8hsBV1YCujzMx__JmJ1PHyjOu8PevsfBiPFmkBqZVHY-n6rRRduupgpgVVtY7V4E-6XSrT8GA0URZTiX4Iq_LUY6lXa9dcH_yr4FNb7o3SgBm-H7x7CjTLOwTuLHsHq_HzhHiN8mpsnYZj8BiApFIY
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFD4amzR4gdFx6bgZCY2nrJ3txM3j6ChjNNXYRZvEg-Vbpmltuq2tBDzxE_iN_BKOnaTT0JAQT4mUk8SXY_s7x8ffAXizafOYtVMRidypiHObRCnCgsjmBu8RstuwY5oNkp0jvnsSn1RRlf4sTMkPMXe4-ZER5ms_wC9s3romDdUj42O0xB1Y4gmOFQ-I9q-po3xSmdK_knr-2LQmnm3TVv3mjaVoybfq19tw5k3YGtad3gP4Upe4DDc535hN9Yb5_geZ4_9VaQXuV3CUbJX68xAWXNGA1a0CTfHRN7JOQoBo8Lw34G63Tg7XgOWs2pNfBbeN1rYlIQKeoJE8JRPlw9SLU3JWECwC2t6h-4n3-ZJ-99ePn9lBKzsgiJfJ5UwV4ZwbzrpEVQwpZJyTyUgNh2RUZu91k0dw1Ht_2N2JquQNkUHIhX2vTYLdLXgn54xrqjcZpyaxljHKRJwnzPDUcZf4xBuOUWVSSq3SmucGMUrKHsNiMS7cUyCMCic6juvcpZzH-DhOdRIrFGozJVwT3tb9KE3FbO4TbAxlyclMJTas9A3bhNdzyYuSzeMWmfWgCnMBdXXuo99ELI8HH2Rnb7-3-7l_KFkTSK0rElvfb7Sowo1nEymwqm2sFm_Ck1KH5h-jgaCIUvxL0IS_FkO-y7r-uvavgq9geW-7J_sfB5-ewb0yyMF7ip7D4vRq5l4gdprql2GQ_AbzFBM-
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dried+blood+spot+sampling+in+combination+with+LC-MS%2FMS+for+quantitative+analysis+of+small+molecules&rft.jtitle=Biomedical+chromatography&rft.au=Li%2C+Wenkui&rft.au=Tse%2C+Francis+L.+S.&rft.date=2010-01-01&rft.pub=John+Wiley+%26+Sons%2C+Ltd&rft.issn=0269-3879&rft.eissn=1099-0801&rft.volume=24&rft.issue=1&rft.spage=49&rft.epage=65&rft_id=info:doi/10.1002%2Fbmc.1367&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_8PRFJQLT_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-3879&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-3879&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-3879&client=summon